description	smiles
In order to modulate gene expression in A-172, synthesize a compound that upregulates ATP13A3, PSD3, FBN1, COL3A1, DPYSL3, COL1A2, GULP1, DLG1, RIPK1, HNRNPH1, HELZ, DENND5A, NFE2L1, GLS, SCD and downregulates ADAMTS6, IGFBP3, CDH13, VIM, HSP90B1, EGFR, ABL2, IFITM3, IFI6, PTMA, FN1, EFNA5, PKM, ZMYND8, TMSB10, S100A11, RRBP1, PPDPF, CSTB, TPM4, SP110, MAP1B, VKORC1, MACF1, ALDOA, SPDL1, RPS19, CDC42EP3, S100A6.	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl
Given a cell population characterized by SW48, design a compound to upregulate the expression of BIRC3, KLF10, NFKBIA, IER2, PPP1R15A, HIVEP2, REL, NR1D2, ZFP36, RPS6KA3, FAT1, CAMTA1, TNFAIP3, NR4A1, SFPQ, HNRNPH1, GADD45B, JUN, DHX9, CHD2, SMG7, TET3, KDM6A and downregulate the expression of CD55, HMGA2, HSP90B1, NDRG1, SERPINB1, ACTG1, HSPA5, P4HA1, LDHA, TMSB10, GPRC5A, GAPDH, CD9, RPL34, PTMA, AGAP1, LRRFIP1, SLC2A1, DIAPH2, RPS6, PPP3CA, RHOA, ITGA2, PABPC1, GPI, RPS8, RCOR1, P4HB, CDC42BPB.	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C
Design an experimental compound for HEPG2 that is designed to activate the expression of ADRB2,NEFL,CXCL14,STXBP1,RGS4,CXADR,VSNL1,NEFL,NTRK2,SERPINI1,E2F2,ATF3,PRAME,MAFF,TNFSF10,SLC39A8,ADAMTS1,KRT5,APOD,DUSP22,C2CD2,TNFSF10,GAGE3,VIM,TGFBR3,SATB1,TNFSF10,CSGALNACT1,GAD1,NCALD,SRGN,SPP1,RCAN2,PDLIM5,TP53,CYTIP,PNMAL1,KIF3B and deactivate the expression of INPP4B,GALNT6,SCD,PPP1R3C,ANPEP,HSPA1A,NEB,FADS1,CFB,H1F0,CADM1,FADS1,CEBPA,KDELR3,CRELD2,ABCC3,KDELR3,TSPAN8,HSPA8,C1R,EFEMP1,KLK12,LAMA3,KLK11,MB.	CCCCCCCCCOc1ccc2[nH]cc(CCN)c2c1
Develop a compound targeting HA1E cells, intended to boost the transcription of S100A8,CA2,C13ORF15,LPAR6,TRDV3,TMEM158,TRD@,RTN1,VEGFA,LYZ,CD40,RTN1,HSD17B6,NELL2,RCBTB2,CHI3L1,LEPREL1,A2M,CXCL9,SELENBP1,HSD17B6,SPON2,SLC14A1,TRIB2,CAMK2N1,VEGFA,AZGP1,DENND1B,HIRA,FCGBP,MYBL1,SHB,VEGFA,SLC2A5,CPE,HBD,FGFR2,ARL4C,ID4,IFI16,PDE8B,MMP7,CHI3L1,FAM69A,TLK2,RGS5,MMP9,LOC100505650,MNDA,MSMB and suppress the transcription of HOXC6,PLAGL1,FAM46A,SRPX,CYFIP2,IMPA2,CDH2,ANXA5,UGCG,CCL21,ZNF238,ALDH1A3,GAS1,TSPAN3,QDPR,RPS11,DKK1,RPL37A,TNFRSF10B,GLS,TYRP1,RPL36,FABP5,TSPAN3,STXBP2,SPRR2B,SPATS2L,ACAT1.	COC(=O)[C@H](Cc1ccccc1)NC(=O)C(=C1OC(=O)C(c2ccccc2)C1=O)c1ccccc1
Considering a group of cells defined as MCF7, formulate a compound that promotes higher expression rates for GLRX,GLRX,SCGB2A2,MAN1A1,MVP,S100P,AKR1C3,TFPI2,CHST15,HMOX1,STC1,SNAI2,NRCAM,TSKU,STC1,CFD,PEG10,KLF10,TFF1,DDIT4,SST,STOM,KRT23,FOXO4,AKR1B10,LAPTM4B,RBP4,HEBP1,TPP1,MMD,KRT19,EPHX1,ALDOC,IL32,PLK2,SAT1,SLC22A18,TSPAN4,CXCL14,BASP1,ZNF91,SCGB2A1,CD24,ZFP36L2,CA2,LINC00341,SAT1,GPX3,ST6GALNAC2,SOX9 and lower rates for RPS4Y1,DDX3Y,ADI1,CDC45,CCNA2,GINS2,ATF5,ATF5,LIG1,IL1RN,PCNA,IGFBP7,SPARC,MCM5,MLF1IP,POLE2,GALNT12,KRT13,CCNA2,SUV39H1,KDM5D,CDC25A,TYMS,ESPL1,EIF1AY,S100A2,KANK1,GSTZ1,TRIP13,FEN1,ZWINT,NPEPL1,GINS1,MCM7,MCM2,PSAT1,FOXM1,DTL,C1ORF116,ESPL1,CDC6,PBK,CDK1,CDC6,PCBD1,MCM5,HMGB2,CDK1,FEN1,TIMELESS.	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1
For a cell population defined as MIA PaCa-2, develop a compound that will upregulate the expression of SLC20A1, HIF1A, PSME4, HNRNPH1, NCKAP1, NFKBIA, CAMTA1, LIMA1, FXR1, EREG, ANKRD28, PPP1R15A, CHD1, IPO7, TMEM41B, QKI and downregulate the expression of GBE1, GAPDH, PSD3, TMSB10, AGAP1, TP63, RAD51B, IFI6, SLCO1B3, LDHA, ENO2, STAT1, P4HA1, TSC22D1, ZNF292, SEMA3A, PFKFB4, KDM4C, HLA-B, ZDHHC14, PLSCR1, GPI, MT1E, GPRC5A, PAM, LOXL2, MBD5, TXNIP, LPP, MT2A, EFNA5, PGK1, SP100, EGR1, MYO9A, TAS2R14, WSB1, SMYD3, ANGPTL4, ZKSCAN1, SMS, ERC1, N4BP2L2, MYO1E, DENND1A.	NCCO.O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O
For cells characterized as VCAP, generate a compound that will enhance the expression of SERPINA3,PPBP,SCD,GLRX,GLRX,NUPR1,ALDH1A3,CDKN1A,CYP1B1,ANXA3,CHN2,LOX,LDLR,MME,IDI1,TRIM2,CDH1,HBD,ELOVL5,IDI1,ABAT and reduce the expression of CXCL13,CLEC2B,VPS72,MCM3,CYP3A5,VCAM1.	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
For cells characterized as HEPG2, generate a compound that will enhance the expression of LDLR,HMGCS1,NR1H2,MAFF,HMGCR,HMGCR,GULP1,MSMO1,HSPA6,DHCR7,CD97,DUSP5,SQLE,IGFBP2,SERPINE1,DKK1,DUSP6,AMIGO2,LDLR,IER3,CHIC2,TRIB3,DDIT3,GUSBP3,FAM60A,PLCB1,DHCR7,DUSP6,HMGCS1,KIAA1199,SQLE,NPC1,CYP51A1,SERPINE1,CHAC1,PPP1R15A,ASNS,CDKN1A,HPCAL1,RGS4,ELOVL6,SNX7,LPIN1,GATA6,BTG1,MCL1,SQLE,CDKN1B,PLCB4,HPCAL1 and reduce the expression of IL17RB,PCDH9,ITM2A,BASP1,RGS1,HLF,KIF20A,SERPINA1,SLC4A4,RHOBTB3,CYP1B1,MXRA5,FGFR3,MMP12,PON2,DMD,MET,POLE2,SLC27A2,NR2F1,TOP2A,CYP1B1,KCNJ16,GCLC,CPS1,PPL,GCLC,RCC1,PON2,PTP4A1,SERBP1,CEBPA.	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
Engineer a compound for PC3 cells aimed at elevating the activity of HMOX1,HSPA1A,CXCL2,DDIT4,HSPA6,PTGS2,IL8,DNAJB1,HSPA6,CHI3L1,ATF3,CSRP1,DNAJB1,NTRK2,JUN,CDKN1A,BAG3,NTRK2,JUN,C10ORF116,CXCL5,JUN,CXCL3,CHI3L1,RCBTB2,FGFR2,GCLM,NR4A2,CD55,HSPA8,TUBB2A,NR4A2,PMAIP1,LTF,NR4A2,EFEMP1,HEPH,CXCR7,HSPH1,CTGF,CD55,NR4A1,IL6,FGFR2,PPP1R15A,SQSTM1,C10ORF10,IGJ,ADM,GPR137B and diminishing the activity of KIF20A,ARHGAP29,CCNA2,SPARC,PRKAR2B,PEG3,TYRP1,KIF2C,TNFRSF21,GNAS,NRIP1,STMN1,SLC35A3,SMARCA1,CCNF,TXNL4B,DKK1,ARL6IP5,C5ORF13,ARL6IP5,MAGED1,SPTBN1,LAMB1,TOP2A,AURKA,ISOC1,ACSL1,OXTR,B3GNT1,CENPA,BUB1,LAMB1,CCND2,IL1B,LGALS3BP,ELK3,SERPINE1,CILP,SMARCA1,CCNB2,TFPI,USP22,DLGAP5,GALNT11,CCDC99,PSRC1,MFAP4,HMMR,SMARCA1.	COc1ccc(C(C(=O)NC2CCCCC2)N(C(=O)CCl)c2ccc(Cl)cc2)cc1
In a cell population characterized as ASC, formulate a compound that will upregulate the expression of SEPP1,PBX1,MMP9,GPNMB,SPARCL1,COL15A1,HSPA6,LMO3,PBX1,APOD,PEG10,CAMK2N1,MFAP2,NINL,CXCR7,OSR2,WSB1,MXRA5,TCEA2,METTL7A,TGFB3,IGFBP5,DNAJB1,PNMAL1,CRABP1,MDK,RARRES1,MEIS2,ST18,INSR,ENTPD1,ELOVL6,ATP2A3,CYP26B1,OGN,FBN2,ISYNA1,CTSK,TOP2A,MTUS1,WSB1,SQSTM1,HSPA6,PDGFD,ENTPD1,NR4A2,GPRC5B,ENPP2,SFRP1,THBS4 and downregulate the expression of SERPINE1,CCND3,SERPINE1,PNP,FOSL1,DUSP4,EIF4EBP1,PFKP,PTX3,PHLDA2,ALDOC,LPL,MYC,SLC16A3,PPARG,NEFL,ENO1,CYB5A,STUB1,LPL,SLC7A11,TM4SF1,MTHFD2,DUSP4,TIPARP,PCOLCE2,CD320,RFC2,ABCE1,WDR61,TM4SF1,PGK1,SLC7A1,SRGN,MGAT2,EIF5A,PSAT1,DDIT4,IL8,GADD45B,GPX1,KLF4,LRRC59,ACTB,ACTN1,CD36,GALE,ANXA6,AK4,TM4SF1.	FC(F)(F)c1ccc2c(c1)Nc1ccccc1S2
With the goal of altering gene expression patterns in CORL23, construct a compound that increases the expression of HMOX1,ATF3,HSPA6,SIK1,SERPINE1,SFN,SERPINE1,DNAJB1,KLF4,HSPA6,HSPA1A,DNAJB1,SFN,CDKN1A,BAG3,ETS1,ANKRD10,GEM,RHOB,KRT17,ZFP36,NDRG1,NR4A1,KCTD5,DUSP1,FOS,RAB11FIP1,GADD45B,DDX21,PPP1R15A,TAGLN,KRT17,GLRX,ERO1L,SLC2A3,BHLHE40,ALDOC,MIR22HG,HSPB8,BHLHE40,GADD45B,KDM6B,PPP1R15A,SFN,MMP12,BNIP3,INSIG1,GATA2,JUNB,MAFB and decreases the expression of SMAD3,GNAS,POU2AF1,GNAS,CD24,CD24,ARHGAP29,SMAD3,FZD7,SCGB1D2,GNAS,CD24,SERPINE2,GNAS,IGJ,BHLHE41,CD24,ARMCX1,SFRP1,ALOX5,FAM129A,CD24,B3GNT1,CXCL14,DUSP4,PLA2G16,MARCKS,PRSS23,ADD3,SUV39H1,POLE2,ARL6IP5,IGLV2-23,FAM3C,CCDC85B,LGALS3BP,IGHD,SPARC,AKR1B1,GUSBP11,SCGB2A2,IGLJ3,IGLV3-19,DLK1,TNFRSF17,CXCL12,CCNA2,SMAD3,TRIM14,NFKBIA.	C[C@@H]1CCCCO[C@@H](CN(C)Cc2ccc3c(c2)OCO3)[C@H](C)CN([C@H](C)CO)C(=O)c2cc(N(C)C)ccc2O1
In order to modulate gene expression in hTERT-HPNE, synthesize a compound that upregulates SMAD3, MYH9, SLC4A7, TRIP12, RSF1, ATP13A3, R3HDM2, CHD2, ACTN1, MBNL1, TFPI, NT5E, SMYD3, SERPINE1, UBE2O, UBR5, SLC2A3, USP34, HIPK3, MICAL2 and downregulates MME, TMSB10, VIM, PTMA, PKM, SUPT3H, RPS24, DSTN, BTG1, TPM4, GLG1, CTBP2, COPB1, ANKRD17, ATM, ADAMTS6, ACBD3, MCFD2, ABCA1, S100A6.	COC(=O)CC(O)(CCC(C)(C)O)C(=O)OC1C(OC)=CC23CCCN2CCc2cc4c(cc2C13)OCO4
Propose a biochemical solution for MCF7 cells which aims to promote the upregulation of ALDOC,NPC1,HMOX1,PEG10,INSIG1,HSD17B11,FOXO4,PEG10,TKTL1,SERPINE2,PLA2G15,LGMN,VIM,RGS2,HIST1H1C,CADM1,MAGEA6,AKR1B1,ETV5,MAGEA3,CDKN1C,GLRX,SAT1,NEU1,EPHX1,PCSK1N,NPC2,FAM117A,FN1,INSIG1,FN1,RRAGD,FN1,IFI27,IL13RA2,GLRX,SCG5,DHRS2,FN1,SAT1,ITM2A,ATF3,BNIP3L,CADM1,FGFR4,DAB2,OAT,SLC2A3,DUSP1,NDRG1 and the downregulation of ESR1,TACSTD2,SPDEF,TFF1,XBP1,GATA3,GATA3,SPDEF,TP53,CCND1,MYC,CCND1,RAB25,PRSS23,RGS5,CCNA2,PLK1,GATA3,ANK3,FHL2,KRT19,RGS5,MLPH,FXYD3,RGS5,ALDH3A1,CA12,TSKU,C10ORF116,CA12,HMGB2,NRIP1,F12,BDH1,TBC1D9,CA12,P4HTM,NBN,NPY1R,CA12,KRT15,KRT13,UGDH,INPP4B,FAM57A,MYOF,NETO2,ERBB2,MAFF,DKK1.	O=C(CSc1nc2ccccc2c(=O)[nH]1)Nc1ccc(Br)c(Cl)c1
For cells characterized as VCAP, generate a compound that will enhance the expression of CSTA,TACSTD2,TNFSF10,MSMB,FAM129A,MSMB,LPAR6,TNFSF10,WSB1,LYN,IGF2BP3,LYN,MAGEB2,SULF1,LTB,TPD52,TBC1D9,TPD52,PARM1,CDH3,IFI44L,IGF2BP3,IFI16,SLC6A8,CXCR4,SFTPB,CXCL13,IFI27,BANK1,HHEX,MS4A1,PXN,ZNF91,GNAQ,MS4A1,TSPAN7,TFAP2A,FAM134B,SFTPB,QPCT,HLA-DQA1,EIF5,BLNK,ZNF274,NPIPL3,RNASE6,PMM2,RAB27A,SPARC,GUCY1A3 and reduce the expression of IFRD2,TGFBR2,TM4SF1,CLTC,TM4SF1,TM4SF1,TGFBR2,TSPAN8,FABP5,MAB21L2,GAS1,GMDS,RBP1,TNC,COMP,EFEMP1,TFAP2B,PCOLCE,PDGFRA,RPS27L,MMP3,MARCKSL1,AREG,CLTB,TM4SF4,CDKN2A,GSTM3,PRKCZ,FLRT2,STOM,CXCL12,SLC1A1,EFEMP1,NYNRIN,PTGDS,NR4A2,ALCAM,SLPI,SLIRP,PI3,NR4A2,PTGDS,ACLY,BCAT1,ADAMTS1,ELN,COL5A2,SEPP1,SEMA3B,DACT1.	N#Cc1c(Oc2cccc(OS(=O)(=O)CCCC(F)(F)F)c2)cccc1C(F)(F)F
Develop a compound targeting VCAP cells, intended to boost the transcription of HSPA1A,CDKN1A,SOX4,IGHM,IGKV1-5,DNAJB1,PNP,SLC25A4,SCGB2A2,INSIG1,SOX4,IGKC,DDIT4,TPSB2,TPSAB1,KLHL21,HIST1H2AC,HMOX1,DNAJB1,TPSAB1,IGHM,SLC31A2,LTF,LGALS3,ZNF423,IGKV4-1,NFKBIB,TFRC,ID3,BZW2,NDRG2,TCL1A,IGLJ3,INSIG1,CA1,IGHD,MAPKAPK2,BAMBI,EREG,IGKV3-20,CCNB1IP1,CD59,TCL1A,IGL@,CLC,ANKMY2,IGL@,IGKC,GMDS,IGHM and suppress the transcription of GNAS,GNAS,UBE3B,GNAS,GNAS,GNAS,CCNB1,P4HTM,PCBD1,HOXB2,UBE2C,BEX4,LY6E,MLPH,IFI16,CDC20,GDF15,ST7,RGS10,IFI16,NPDC1,TACSTD2,FCGBP,BIRC5,BCHE,SPINK1,GUCY1A3,IGFBP3,CNDP2,MSMB,ESR1,CDH1,CKAP4,SPDEF,PTGIS,OBSL1,LAPTM5,RAMP1,CTSZ,TGM2,GNAS,TBL1X,MYO6,POLR2I,DPYD,MYC,MXRA5,TDO2,TM9SF3,TFPI2.	CCCSP(=O)(OCC)SCCC
Engineer a compound for A549 cells aimed at elevating the activity of AREG,OLFM4,ZNF91,GOLGA8A,GLUL,POSTN,ALB,SMC1A,GLUL,RNF128,CTSZ,ISG15,FEZ1,DPP4,PSTPIP2,HES1,HIST1H1C,TREM1,RALGDS,FHOD3,ZFP36L2,CCL5,BHLHE41,CCND2,PBX3,DPP4,SFRP4,IFIT1,DTX4,DPP4,GOLGA8B,GLUL,DUSP14,OBSL1,PCDH7,EI24,STS,CADM1,CDKN2A,NR4A2,RCBTB2,RSL1D1,AZU1,LPAR6,RAB38,DDX21,NT5E,CDKN1A,TMEM30B,GALNT3 and diminishing the activity of KDM5D,UBQLN2,NTS,GPR64,MAGEA3,ID1,HMGCS1,POLE2,FABP5,FXYD2,ALDH3A1,IGFBP4,MAGEA6,LBR,RHOB,CCNA2,FXYD2,SMS,DDX3Y,HPGD,ALDH2,SERPINB9,NUP88,MTHFD2,RAP1GAP,HPGD,KLF4,ANXA7,SERPINE2,ID2,EZH2,MAP7,NNMT,AQP3,IER3,EIF5A,FGG,ALDH1A1,HPGD,TFPI,AKR1C3,PROM1,ASNS,USP22,TESC,MAP7,CLIC4,ENPP2,ABLIM1,IMPA2.	O=C(CSc1nnc(-c2ccccc2Cl)n1-c1ccccc1)Nc1ccc(Br)cc1
Given a population of cells identified as COLO 205, create a compound that will increase the expression of the following genes: PTPRF, BCLAF1, RNF43, B4GALT5, PTEN, PJA2, DLG1, UBE2D3, RALGPS2, N4BP1, USP3, CSNK1A1, ANKRD11, SREBF2, OSBPL2, RAB3GAP2, ENOX1, TNFRSF10B, WDFY3, PHC3, KDM5B, RBM39, ABCA5 and decrease the expression of the following genes: EGR1, JUN, CYP3A5, PLSCR2, GAPDH, ANXA2, STAT1, IFI6, XAF1, POU2F2, PTMA, MX1, MX2, INTS6, MYO1E, CTSD, DDIT3, SLC38A2, SAT1, FTH1, HKDC1, NT5C2, HSPA5, CUX1, SP100, ARPC2, RPS24, ALDOA, GULP1, EZR, IFIH1, CDH1, ANKRD10, IFIT1, PHLDA1.	O=C(O)C(=O)O.[NH-]C1CCCCC1[NH-].[Pt+2]
With the goal of altering gene expression patterns in SW 1271, construct a compound that increases the expression of IER3, ATP9B, FAM13B, ABL1, RPS12, ULK1, ATAD2B, RHOT1, UBR2, OAZ1, PPP4R4, PRPF6, SFPQ, STRAP, REL, HSPD1, HNRNPA2B1, CRYBG3, HDGF, RPL9, BRD4 and decreases the expression of KCNMA1, DLGAP4, HMGA2, DST, BACH1, CANX, KPNB1, UBE2K, RAI14, TMEM123, KIF5B, RAB3GAP1, TFG, IL1RAP, PIBF1, SLC4A7, PUM2, CD2AP, AHNAK, SERPINE2, P4HA1, ZBTB38, NEDD4, GNAS.	O=C(O)c1ccccc1O
For cells characterized as A549, generate a compound that will enhance the expression of COL11A1,ZNF91,FARP1,GPNMB,FDFT1,FEZ1,COL11A1,DSP,FDFT1,VTCN1,ADD3,HMGCS1,MFAP5,INSIG1,SERINC5,MME,SC5DL,ZNF586,COMP,SULF1,CTSZ,DHCR24,MSMO1,SCUBE2,S100A8,TRIM22,DTX4,ACAT2,CFB,CD9,RFNG,DRAM1,GOLGA8A,MME,GMPR,FARP1,NUPR1,SORL1,ZMAT3,FZD6,TFAP2A,IDI1,SFRP4,SPINT1,DHCR7,ADD3,BIK,COL10A1,IDI1,DKK3 and reduce the expression of STX1A,RNF167,FABP5,POLE2,IGFBP4,CXCL12,CDK1,PLK1,PLAC8,GPR64,TPM1,EZH2,TCN1,OLFM1,TPM1,PPP2R3C,SERPINE2,SRGN,MAGEA3,CDKN2C,HOXC6,CCNA2,SRGN,TGFBI,DKK1,ITM2A,TFPI,COL6A3,IL8,TCF4,PSPH,CDC25A,UBE2C,OLFM1,MAGEA6,CLTB,MYCBP,CA12,DDX10,TPM1,KRT10,MYCBP,RBP1,PRSS3,HPRT1,MT1M,TPX2,CD59,RGS2,TUBA4A.	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1
For cells characterized as A375, generate a compound that will enhance the expression of TRIM22,CDKN1A,C10ORF116,ZMAT3,CXCR7,ASS1,SESN1,HIST1H1C,NUPR1,CRYAB,RGS2,HIST1H2AC,PEG3,PRUNE2,HSPA1A,ZSCAN18,CRABP2,PEG3,GJA1,CCNG1,FTH1,TOX,GPNMB,PLXNB2,DDB2,XIST,RNASE1,FDXR,RGS1,FXR1,CITED2,HIST1H2BD,GLUL,SERPINF1,NXN,ATF3,ALDH5A1,CES2,CITED2,LDB3,GLUL,WSB1,CPE,BTG2,XIST,PTGER4,NOTCH1,KCNJ2,HIST1H2BK,CCND2 and reduce the expression of DUSP6,IER3,DUSP6,FOSL1,DUSP4,DUSP6,PHLDA1,HLA-DRA,TM4SF1,IGFBP3,HLA-DRA,TM4SF1,TM4SF1,DUSP4,DKK1,IGFBP3,ETV1,SPRY4,TLR4,DTL,CCND1,CDC25A,TNC,PHLDA1,CCND1,ALDH1A3,TGFBI,PLAT,AURKB,LEF1,TCN1,ELK3,SFRP1,MGP,TMEM2,PHLDA2,STC1,CCNA2,PTPN12,PHLDA1,TGFBR2,CENPA,MLF1IP,FABP5,ITGA6,MCM10,HLA-DPA1,MYBL2,CXCL1,FEN1.	CC(C=CC=C(C)/C=C/C1=C(C)C(O)CCC1(C)C)=CC(=O)O
Given a population of cells identified as NCI-H1792, create a compound that will increase the expression of the following genes: NAMPT, SMAD3, HIF1A, MAP3K2, FLNB, CHIC2, PLEKHA2, FAM13A, MPZL1, IL6ST, CLOCK, PTPRR, SECISBP2L, RSRC2, PDGFC, RIPK2, EVI5 and decrease the expression of the following genes: MYC, PTGS2, FN1, SAMD9, DST, MAGI2, ENO1, FBN1, ERN1, ERO1A, KCNMA1, INTS6, AADAC, ALDOA, ITPR1, PRKCA, LOX, SERPINE2, NRG1, RPL35A.	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)([O-])[O-])C(=O)C(C)(C)O4)n2)cc(OC)c1OC.O.O.O.O.O.O.[Na+].[Na+]
In order to modulate gene expression in HA1E, synthesize a compound that upregulates OLFM4,CPE,LPAR6,AIM1,KRT19,CPE,PTGS1,ROBO1,FN1,RTN1,RTN1,REG1A,SPON2,MEIS2,OSBPL10,JAG1,TBX3,ADH1B,EPAS1,ADH1B,A2M,CD40,LGR5,S100P,CXADR,C7,DEFA5,VTCN1,PTGS1,PLCB1,EPCAM,NELL2,CORO1A,EFEMP1,SDC1,SNAI2,MAOA,PCSK1,TRIM2,TRIM2,FRZB,GABRP,KCNK3,PLN,BCHE,MYH11,KLK3,PLEKHM1,JAG1,DENND1B and downregulates POLR2I,CAPNS1,TBCB,CLU,TBCB,TBCB,CLU,PFKP,KRT7,OXTR,UCHL1,RRAGD,SLIRP,GPI,NPC2,ACOT9,ACAT1,HTATIP2,DEFB1,TMEM147,GRB14,RPL38,HN1,RPS11,SPATS2L,REEP5,SLPI,MFSD10,CELF2,CDKN1C,CELF2,ANKRD27,COX6B1,PHYH,IFI27,BAG2,PLIN3,RPL38,SNAPC1,S100A11,FABP5,C14ORF1,GCA,PEBP1,IL8,NFIB,CDH2,GOLGA8A,TXN,ECI2.	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@@H]3OC[C@@]3(OC(C)=O)[C@@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C
In order to modulate gene expression in PC3, synthesize a compound that upregulates CRIP1,GJA1,KRT13,SOCS2,SYBU,IGL@,IGFBP7,IL1B,IFI27,C10ORF116,VEGFA,NEDD9,IL1B,CKB,CD9,IL8,GSTP1,PALLD,GRIA2,TSPAN13,LGR5,EMP1,GSTT1,TRIM2,TGFBI,HIST1H1C,MAFF,CXADR,ID1,PIR,YTHDF1,NEBL,IGFBP7,VEGFA,MST4,TRIM2,KIAA0485,POLG2,VEGFA,MCAM,CAST,SERPINB1,CAST,ECM1,FHL1,NEBL,EMP1,SPRY2,FGFR2 and downregulates GOLT1B,DAPK1,PLK1,MARCKS,CXCL12,LMO4,DKK1,OXTR,BAX,KIAA0182,CXCL12,MARCKS,KIF20A,SNX7,FCER1A,MTDH,CHI3L1,CHI3L1,CLEC2B,AZGP1,SFRP1,KIAA0182,CCL18,GNAQ,FST,TEX10,KRAS,JUN,PSRC1,GLUL,RGS10,HSD17B2,PLXNC1,KRT23,BMP4,NGFRAP1,FNBP1,HOXC6,ITGBL1.	CCCSP(=O)(OCC)SCCC
Design an experimental compound for AN3 CA that is designed to activate the expression of CHD7, NUCKS1, PNISR, OLA1, FRYL, LUC7L3, PCBP2, YWHAE, SMC5, NAP1L1, EP300, ETNK1, EP400, SREK1, COPA, SLK, TMEM123, NDUFV2, TCEA1, DDX42, TRIM33, CDC42BPB, BRWD1, SUCO, PSMD11, GPR107 and deactivate the expression of GNB1, IER3, HMGA2, PAM, MGP, FBXO11, RPS8, ENO1, SEC14L1, LDHA, SMAP1, SIK3, ACTG1, BCAS3, CALD1, ATF6, MICU1, ALDOA, PDE10A, SMS, RRBP1, ITGB1, VIM, HSP90AA1, PLOD2, SCD, RPS4X, TPK1, CLTC, FAM193A, TET1, TPP2, TRIM9, WASF2, CCT4, MED27.	O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCN(C(=O)C2CC2)CC1
Considering a group of cells defined as THP1, formulate a compound that promotes higher expression rates for HMOX1,DDIT4,CD24,SLC7A11,GDF15,CPE,TSC22D3,ASNS,CD24,ATF3,STC2,TRIB3,ASS1,NTRK2,NUPR1,WARS,STC2,CD24,CD24,CPE,PPARG,SLC7A11,WARS,C1QB,CD24,PCK2,DUSP1,DDIT3,HIST1H2AC,NNMT,HIST1H1C,C1QA,IFIT1,PEG10,AMDHD2,CLDN3,SCGB2A2,VEGFA,GPR64,NDUFA4L2,RHOB,TNNT1,NNMT,KRT18,SARS,PSAT1,TES,KRT8,PLIN2,CD24 and lower rates for CDC25A,ZDHHC6,JMJD6,FLRT2,CCNE2,ICMT,SORD,PRKAR2B,TCN1,RRP1B,FEN1,SRSF1,PRKCD,POLE2,NR2F2,SFRP1,GSTP1,SFRP1,SLC26A2,NR2F2,EXOSC4,EGR3,CHERP,MSH6,CES1,GINS2,MSH6,MMP9,IGFBP7,MYB,ALDH18A1,MRPS2,SKP2,TNFSF10,OAT,TNC,CCL19,CCNE2,IKBKE,DNAJC9,PRKCB,PCYOX1L,NOLC1,SERPINB3,JMJD6,KIAA0101,ARFIP2,TMEM97,TSPAN3,PPIF.	CC(C)(C)Sc1c(CC(C)(C)C(=O)O)n(Cc2ccc(Cl)cc2)c2ccc(OCc3ccc4ccccc4n3)cc12
Create a substance that, when applied to VCAP, will enhance the gene expression for LTF,SERPINA3,KLK11,CYP1B1,FABP4,ACSL3,SLC26A2,SAT1,NKX3-1,CYP1B1,SAT1,TIPARP,LDLR,DDIT4,ATF3,CYP1B1,POLD4,GLRX,GLRX,ACOT9,SPDEF,MAFF,INSIG1,HOMER2,C6ORF62,SC5DL,FOXO4,ADIPOQ,KIAA1324,SHANK2,GOLT1B,BIK,SAT1,CIDEC,NFKBIA,SPDEF,KDELR3,NUCB2,CDKN1A,RBM47,SERINC5,PLIN1,CLIC5,SNAP23,ARMCX3,PRKCD,RNASE4,PEG10,WIPI1,PDXK and reduce it for IGFBP3,IGFBP3,MYC,LIG1,ST7,DTL,CDK1,BRCA1,TFPI,TYMS,BCHE,IGL@,PCNA,STMN1,MELK,CDC25A,KIAA0101,CXCL14,TP53,GINS2,CCNA2,GGH,UBE2C,ENPP2,TRIP13,KIF15,LAPTM4B,HELLS,ZWINT,GINS1,CCNA2,HLA-DQB1,CCDC85B,FANCI,CCND2,CKS2,DHFR,ASPM,EXO1,LY6E,MCM10,MCM2,KIF11,RRM2,PBK,CENPF,MCM3,PRR7,CHEK2,HIST1H4C.	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21
Given a cell population characterized by SKMEL28, design a compound to upregulate the expression of SESN1,HMOX1,TRIB3,TSC22D3,ASNS,KRT15,CRABP2,MTHFD2,MMP7,FAM129A,CSTA,CNPY3,HBB,CYP1B1,MME,TLR4,PCK2,CYP1B1,PAPSS2,CLGN,TGFA,AMIGO2,AQP3,PPP1R3C,GCLM,CD44,SLC7A11,HBB,TRD@,S100A8,CYP1B1,DDIT3,HERPUD1,MME,C3ORF14,NPTX2,CHST15,KIAA1199,CPE,ARG2,CEACAM6,GREM1,EPAS1,SHMT2,SDC1,PAPSS2,SDC1,INPP4B,CALML3,POSTN and downregulate the expression of EXOSC4,F2RL1,DMD,FAM57A,CCNB1,MSX1,HPGD,HPGD,ALDH1A1,HPGD,PIK3R3,OXA1L,F2RL1,DDX3Y,F3,ECI2,AURKA,WFDC2,CAPN3,MTUS1,UBE2S,MATN2,AKAP12,CYCS,RARRES1,IGF2BP3,HPGD,CDH2,PLCB3,SLC26A2,PKP2,NGFRAP1,CCNA2,AURKA,ITM2A,TCF4,EXOSC4,RARRES1,GATM,COL9A3,PLA2G2A,ERAP2,LBR,EXOSC4,TGFBR2,HS3ST1,SRSF6,CAPN3,ST3GAL5,WBP5.	CCc1ccccc1NC(=O)CSC(=O)NNC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
For cells characterized as SW948, generate a compound that will enhance the expression of EGR1,HSPA1A,HSPB1,HIST1H1C,BAG3,ATF3,EGR1,DDIT4,HIST1H2BK,NFKBIA,HSPA6,H2BFS,JUN,TNFAIP3,EFEMP1,JUN,FHL1,GADD45A,HSPA6,IL8,IER3,TNFAIP3,JUN,CXCL2,IGFBP7,ROBO1,HIST1H3H,RCBTB2,IER5,HIST1H2AC,IL1R1,C1QA,SRGN,C10ORF10,FOS,BEX4,PTN,CLDN10,H1F0,FHL1,DDIT3,GPNMB,PTN,PPP1R15A,HIST1H2BD,DUSP1,HSPA2,IGFBP5,PPP1R15A,MT1X and reduce the expression of TM4SF1,MARCKSL1,TM9SF2,TM4SF1,TLR4,MET,TCN1,FAM57A,CD24,TGFBR2,ARL6IP1,TM4SF1,CD24,VPS28,CD24,KANK1,TSPAN13,CD24,ACSL5,GTF2E2,MAT2A,CD24,ESR1,MARCKS,IL13RA2,SLPI,PDIA3,MPZL1,ASPH,CXCL14,C20ORF3,CD164,LYPLA1,CD99,MYCBP,TSPAN3,SERPINB5,RPA1,CCDC47,AQP3,TMEM2,SLC1A1,PRDX1,MPZL1,PRSS3,TRIM14,CD59,CD99,RAB11A,CEACAM1.	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
Considering a group of cells defined as A549, formulate a compound that promotes higher expression rates for KRT19,CPE,S100P,IGFBP7,ISG15,CPE,IGFBP5,RGS5,TSC22D3,RGS5,AZGP1,CDH11,SERPINE1,SERPINE1,DDIT4,C10ORF116,ARG2,GLUL,RGS5,PTN,ATF3,SERPINB2,MMP1,BEX4,ANGPTL2,ATP11B,PEG3,ABAT,ORM1,NUPR1,FGFR3,BGN,PRKAR2B,SPINT1,GADD45B,GFOD1,LGR5,HSPA2,ZNF423,CXCL12,A2M,HRSP12,RCAN2,FXYD6,FLT1,VNN1,CCND2,LOXL1,ASS1,LPHN2 and lower rates for CXCL5,PRR7,AKR1C3,CDCA4,BAG3,TUBB6,ITGB1BP1,PLK1,FASTKD5,GABRE,NRN1,PRKCA,CXCL5,MAPKAPK3,NUDCD3,KYNU,TRIM16,TM4SF1,TGFBR2,TM9SF3,GAA,PON2,KCNN4,ME1,LTBP3,HOXA5,TM4SF1,ATP6V0E2,SLC39A8,SLC39A8,STXBP1,EMP3,CDC25A,CASP8,PMP22,HMOX1,POPDC3,ECI2,KYNU,HSPA8,ENO2,TGFBI,PIP4K2B,SLC7A11,DUSP22,SACS,KYNU.	CCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C
In a cell population characterized as A549, formulate a compound that will upregulate the expression of A2M,G0S2,FN1,MMP9,CD93,SERPINF1,NPTX2,TSPAN7,TGFBR2,KRT19,GPX3,PECAM1,CPE,PCK1,CHI3L1,TACSTD2,ELTD1,EMP1,EGR2,GPX3,SCGB2A2,SNAI2,TIMP3,S100A8,CPE,KRT5,IGFBP5,TGFBR2,CXCL14,GLUL,PECAM1,THBS1,ISOC1,GSTA1,TMSB15A,SCGB1D2,GPNMB,MAOB,CDH5,FAM198B,C3,KRT23,APOD,DCN,CPB1,LPAR6,VTCN1,YTHDF1,COL15A1,PECAM1 and downregulate the expression of EGFR,UBE3C,KRT7,ABCA1,TMEM2,ABCA1,CCNF,KIAA1033,PHF15,CLTC,TRAK2,KIF14,EXOSC4,GOLGA8B,COL4A5,PRKCA,RPL31,BRCA1,CHD9,TNFRSF10B,IGHD,ANKRD36B,PPARG,NUP62,KIAA0485,MED13,ASXL2,C12ORF24,CDK12,PION,FNDC3B,BAZ1A,ERBB2,PIP4K2B,PCM1,LONP2,IGKV1-5,LIMCH1,PION,PCM1,PCBP4,PBX3,TACC2,SLK,CEP350,PTPN12,NAV2,GOLGA8A,PMS1,WSB2.	CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
Engineer a compound for A375 cells aimed at elevating the activity of GADD45B,GADD45B,FOS,GADD45B,FOSB,RGS2,EGR1,ATF3,ZFP36,EGR1,JUNB,KLF4,KLF2,HSPA6,S100A8,MYC,JUN,JUN,CXCR7,NFKBIA,PTGER4,DUSP1,CTGF,KLF4,RHOB,SOX4,NR4A1,THBS4,IER2,HES1,ID3,ID1,SFRP4,ESR1,BTG2,AQP1,CHI3L1,PDGFRL,KLF6,ID2,PLAU,IER5,SOX4,JUN,ZNF586,EGR3,TRD@,TFF3,DEFA5,FZD7 and diminishing the activity of TRAPPC3,RPS6KA1,TOP2A,GLIPR1,MRPS2,TNFAIP2,SOX11,DPYSL2,COG2,CA12,MBOAT7,CA12,ZDHHC11,EFHA1,TMX4,ACSF2,SOX11.	CC(C)=CCCC(C)(OC1OC(COC2OC(CO)C(O)C2O)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C
With the goal of altering gene expression patterns in HME1, construct a compound that increases the expression of NUPR1,GPNMB,GNAI1,CFD,HMOX1,CRYAB,PAPSS2,HSPA1A,CDKN1C,DCN,CD24,FTH1,RHOBTB3,SQSTM1,TPD52L1,CDKN1C,CXCR7,ATF3,SQLE,C1R,FADS1,MXI1,SOD2,TNFSF10,NFKBIA,GRN,TMEM45A,QPRT,SCPEP1,SPON2,GM2A,CECR1,CDKN1C,DAPK1,ASS1,DCN,C1S,MME,SQLE,PSAP,CD24,KLF4,CD24,FADS1,GRN,PLBD1,HSPA6,CD55,PAN2,ZNF91 and decreases the expression of IARS2,PHLDA1,LTF,STEAP1,DUSP6,PHLDA1,DUSP6,TGFBR2,PLK1,SPP1,PHLDA1,TGFBR2,MARCKSL1,CBFB,PTGS2,SOX9,ASPM,UBE2S,YKT6,PHLDA1,RRM2,CCNA2,CDC25A,CENPF,LRIG1,NEK2,BUB1,IL1R2,POSTN,CCNF,STMN1,KIF20A,DUSP6,UBE2C,SFRP1,BIRC5,CDK1,MKI67,MKI67,AURKA,CCND1,KIF18B,DCK,SHCBP1,CDK1,AURKA,TPX2,UAP1,CDK1,SPRY2.	CC(c1cc2ccccc2s1)N(O)C(N)=O
Design an experimental compound for A549 that is designed to activate the expression of HIST1H1C,HLA-DQA1,ALDOC,MAGEA3,INSIG1,PLA2G15,MAGEA6,INSIG1,TACSTD2,AZGP1,INSIG1,PRDX2,AZGP1,HIST1H2BD,NEU1,HIST2H2BE,CYB5R1,ACP5,DHRS2,MAGEA12,MGP,SCPEP1,FAM117A,ALOX5AP,DHCR7,TNFSF10,KRT19,GRN,GRN,CITED2,NOSIP,TRIM36,TM7SF2,C1QB,BEX4,CITED2,NPIPL3,LDOC1,FXYD6,SLC24A3,PPARD,RGS16,COL3A1,S100A8,C1QA,CLDN3,ZNF91,TPP1,PEG3,HBP1 and deactivate the expression of AKR1C3,TM4SF1,CA12,CA12,ALDH3A1,CA12,ITGB5,TGFBI,AKR1C1,S100A10,TM4SF1,RCN1,ANXA1,AKR1C2,UGDH,SLC7A11,CA12,AKR1C2,TM4SF1,PIR,SMAD3,GDF15,GPX2,AKR1C1,CRIP1,HOXB7,NETO2,PON2,ALDH1A1,IGFBP4,CCND1,SMAD3,CA12,SPR,RPL37A,SORBS3,POLE2,TSKU,MYC,ADM,HOXB7,TFPI2,EIF5A,CAST,IGF1R,PON2,COL5A2,SLC7A11,CDK4,CXCL5.	CCCc1cc(-c2nc(-c3ccc(C)cc3)cs2)ccn1
Engineer a compound for A549 cells aimed at elevating the activity of NRIP1, ANGPTL4, SMAD3, CYP24A1, BCL2L1, RASA2, SHB, RARB, BCAR3, LHFPL2, UBA6, TGM2, SKAP2, HNRNPA2B1, MED13, ATRN, PPFIBP1, RAI14, MYH9, GRAMD1B, HNRNPH1, DPY19L1 and diminishing the activity of IGFBP3, ACTB, HSPA5, S100A6, PTGS2, AKR1B10, GAPDH, NDRG1, PRKCA, FTL, TMSB10, CXCL5, MON2, P4HB, MBD5, ACTG1, LDHA, RPLP1, GPATCH2L, AHNAK, RPL35A, CCDC88A, PSMD5.	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1
Given a population of cells identified as A549, create a compound that will increase the expression of the following genes: TRIB3,SERPINE1,PEG10,TSC22D3,STX1A,RNF167,SERPINE1,KLF4,CXCL2,PEG10,G0S2,PCK2,ARMCX1,MAPK1IP1L,PTX3,ASNS,HBB,PRNP,DCLK1,OLFM4,KRT14,C10ORF116,IGFBP7,AOX1,CFB,MAPK1IP1L,HBB,EFHD1,FOSB,JUND,FABP4,AMIGO2,TNS1,MAFF,XBP1,C6ORF62,DUSP1,SHMT2,ENOPH1,SHMT2,PPP1R3C,CTH,PHLDA2,AREG,NAV2,KLF2,MPZL1,HDAC9,SIK1,UGDH and decrease the expression of the following genes: KIF20A,TIMP3,PGAM1,PSPH,CCNA2,VCAN,TIMP3,VCAN,PI3,WNT5A,HOXC6,TCN1,SERPINB3,CCNA2,HOPX,KLHL9,TIMP3,PPBP,PI3,CKS2,C1QTNF3,KIF11,COBL,EPHA3,HCAR3,SERPINB3,IMPA2,SLPI,VCAN,SERPINB13,CLC,HOMER3,HEATR1,ANK3,PPIF,SCD,FCGR3B,TFF3,GSTZ1,TECR,COL5A1,PPIF,RAB25,MMP11,PXDN,KLK10,SORD,OAS1,C5ORF13,RAB11A.	CC1(C)CC(=O)C=C(SCC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)S1
Given a cell population characterized by RKO, design a compound to upregulate the expression of KDM5B,DCN,DCN,DCN,THBS2,PSMD10,CPE,BTG2,CILP,BEX1,CA2,CD24,SESN1,PTGER4,CD24,CYP1B1,DCN,CPE,CHAC1,C3ORF14,OLFM4,MAGEA3,DDB2,CHMP4A,ASPN,ASS1,CYP1B1,TLR4,COL5A2,NGFRAP1,PPIC,HSPH1,DNAJC6,KRT19,PRKACB,MAGEA6,MMP10,CRISPLD2,NPTX2,GNAS,ABAT,APOD,SLC38A2,PTN,COL11A1,CHI3L1,KRT8,CD44,COL4A5,PTN and downregulate the expression of PSMB8,BTK,PLK1,PHLDA1,TNS3,BST2,IMPA2,DAPK1,PHLDA1,TFPI,ANKRD10,LPP,ABHD2,KANK1,ENO1,PLSCR3,NAV2,TRIB2,HPRT1,BZW2,WNT5A,CCND1,MGLL,DAB2,NGRN,IFITM1,CAPN2,IFITM1,IFITM2,RRS1,LPCAT1,MEF2C,FGF13,PTPN2,DDX21,ABHD2,PRKCA,MX2,LTBP1,KAZN,ACTC1,RBMS1,CD59,SDC2.	O=C(O)c1ccc2cc(-c3ccc(O)c(C45CC6CC(CC(C6)C4)C5)c3)ccc2c1
Create a substance that, when applied to HA1E, will enhance the gene expression for INSIG1,HMOX1,INSIG1,INSIG1,CFD,ELANE,SLC6A8,NUPR1,TNNT1,CITED2,HMGCS1,ABHD4,CDKN1A,BLVRB,MS4A3,BCL6,CRABP2,CXCR7,ISYNA1,GULP1,C14ORF132,MAOA,DDX3Y,GULP1,C7ORF68,LMO3,PHGDH,SLC2A3,EIF1AY,TCEAL2,MSMO1,IL1R2,CA2,EPHX1,GLUL,SLC6A8,RXRA,MAOA,CENPE,HBP1,PBX1,CCNG2,MAOA,PRTN3,MPO,CRISP3,SMARCD3,CITED2,SNCA,TMEM47 and reduce it for IER3,SOX9,CCND1,KRT7,PMEPA1,SOX9,PLAT,FOSL1,DUSP4,CCND1,TM4SF1,TM4SF1,MYC,TM9SF3,DKK1,ELK3,TM4SF1,MAP1B,ALCAM,LGALS3BP,CXCL1,VCAN,ITGA6,XPNPEP1,P2RX5,ITGA6,PLAU,VCAN,EFNB2,POSTN,SLC39A8,CYTH1,DLC1,SERPINE1,PLAU,MET,SLC39A8,LIF,MMP7,NELL2,G3BP1,DNAJC12,NOLC1,SPOCK2,TGFBI,TGM2,ETS2,TUBB2A,SIK1,DDX21.	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1
Given a cell population characterized by PC3, design a compound to upregulate the expression of CHAC1,ASNS,PHGDH,CAST,CXCL9,SLC1A4,EPHB2,CAST,ASS1,TRIB3,ABL1,PCK2,CXCL11,PSAT1,SLC1A4,KIF20A,ATF4,RARRES1,NUPR1,SLC7A5,WARS,TNC,IDO1,WARS,PLAGL1,IARS,CAST,AARS,SMC1A,SLC1A4,ME1,CARS,CAV2,CEBPB,YARS,DDIT3,CNN3,BCAT1,GADD45B,HERPUD1,RARRES1,CAV1,TBL1X,CXCL11 and downregulate the expression of CCL20,BEX1,KRT19,VAV3,CD24,NFATC3,CD24,GSTM3,C20ORF103,S100A8,SNAP25,WNT5A,SNAP25,IL8,MLLT11,MAGEA3,CXCR4,CADM1,CD24,CCP110,CD24,HOXC10,FGFR2,LTF,VTCN1,CD24,CADM1,PLAC8,CADM1,SLPI,CHN1,TACSTD2,HOXC6,MAGEA6,NAT1,SCGB1D2,SCGB2A1,PTGS2,LPL,SDC2,DENND1B,IL1B,SLC25A13,STMN2,PI3,FGFR2,GPM6B,DSP.	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(/C=C/c4cnc5[nH]ccc5c4OC)c3)cc2C(F)(F)F)CC1
For cells characterized as VCAP, generate a compound that will enhance the expression of HMGCS1,HMGCS1,INSIG1,MSMO1,INSIG1,IDI1,CYP51A1,NSDHL,IDI1,INSIG1,EBP,EBP,NSDHL,FDFT1,DHCR7,DHCR7,CD24,SCD,SCD,SQLE,LSS,ACLY,ALDOC,FDPS,TXNDC9,LIPG,ELOVL6,FDFT1,CFD,GAGE3,GJA1,CDH1,LSS,PTPLA and reduce the expression of SLC4A4,EIF1AY,LGALS3BP,SEPW1,BST2,IFI44L,RBP1,COCH,COL3A1.	COc1cc2c3cc1Oc1c(OC)c(OC)cc4c1[C@@H](Cc1ccc(OC(=O)c5ccc([N+](=O)[O-])cc5)c(c1)Oc1ccc(cc1)C[C@@H]3N(C)CC2)N(C)CC4
Design an experimental compound for PC3 that is designed to activate the expression of PHGDH,DDIT4,PLCB1,CPA3,ABAT,SERPINA1,ZIC1,WLS,PSAT1,SERPINA1,METRN,NET1,S100P,IGKV4-1,WNT5A,WARS,SLC7A11 and deactivate the expression of SCGB2A2,BIRC5,PGAM1,HMGCS1,MARCKS,HPGD,MARCKS,TYMS,MICAL2,HPGD,EI24,GINS2,KIF2C.	C[C@@H]1CN([C@@H](C)CO)C(=O)c2cccc(NC(=O)c3ccncc3)c2O[C@H]1CN(C)Cc1ccc(Oc2ccccc2)cc1
Considering a group of cells defined as HA1E, formulate a compound that promotes higher expression rates for FAM69A,XBP1,GPC1,NRIP1,TPD52,HERPUD1,IGLJ3,TLR4,FAM69A,CLIC4,ENOPH1,SRGN,GBP1,MYO6,CXCL14,TPD52,IGKV4-1,IGJ,ME1,PPP1R3C,TPD52,SLC14A1,HOPX,TACSTD2,CLIC4,SCRG1,CD24,AMIGO2,IGHD,SRGN,PEA15,NRIP1,MAP7,LOC100505650,S100A10,IGLV3-19,CD9,KIF1A,CD24,IQGAP1,CD24,SST,HBB,EEF1A2,GJA1,IGKV1-5,REEP5,CA1,LXN,EIF4G1 and lower rates for IKZF1,GAS1,BAD,TCN1,SLC25A14,PEG3,EBP,ACACB,PLTP,NTS,RPIA,NQO1,GOLGA8A,HSPA1A,ITFG1,PLAC8,PCM1,CASP7,IL8,TESC,IRS2,AFP,FST,RNF130,ALDH1A1,EBP,IRS2,NETO2,FCGBP,PTGS2,OLFM4,PCM1,IL2RG,GMDS,HOXC6,NQO1,GALNT2,IL7R,ACACB,APOA2,ID1,FYB,DKK1,USP11,WFDC2,ITM2A,SRPX,TCF7,COASY,CRIP1.	CCCCCCC1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C
For a given cell population identified as VCAP, design a compound to increase the expression levels of these genes: HMGCS1,CYP1B1,ADAMTS1,PROM1,MAPK6,QPCT,VCAM1,PLAT,FGG,S100A8,SERPINE2,UBE2A,DST,IDI1,DST,NOV,GABRP,VDAC1,DUSP10,ARPP19,BAG3,GLRX,DNAJC6,GLRX,PTP4A1,ANKRD10,IDI1,DSG2,XK,FASTKD5,PTP4A1, while simultaneously decreasing the expression of these genes: CD24,CD24,CD24,CREB1,ATM,FABP5,SEPP1,COL3A1,CADM1,NPIPL3,EIF5A,IL7R,TWIST1,IL1B,IL1B,MXRA5,GALNT6,PDCD4.	Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O
Develop a compound targeting NCI-H2122 cells, intended to boost the transcription of POLR2A, PTPRG, WNK1, BAZ1A, PIK3R3, ARL15, EPHA4, RAD51B, IPO7, CFL1, DLEU2, MCL1, B2M, CDK7, APLP2, RPS12, BMPR2, RCC1, PABPN1 and suppress the transcription of ANXA2, NDRG1, ERO1A, AKAP9, ITGA2, GBE1, PGK1, GFPT1, LPP, MYO1E, TAS2R14, BACE2, GAPDH, ZNF638, CDK13, JMJD1C, DST, ATP2C2, ARPC2, ZMYND8, PHLDA1, ITGA3, FLNB, AKAP13, SCFD1, NF1, LDHA, RRBP1, MON2, PSD3, PLSCR1, PAM.	CC(=O)C1(O)Cc2c(O)c3c(c(O)c2C(OC2CC(N)C(O)C(C)O2)C1)C(=O)c1ccccc1C3=O.Cl
For a cell population defined as VCAP, develop a compound that will upregulate the expression of DDIT4,NUPR1,HERPUD1,ARHGEF2,PCK2,SLC7A11,RCBTB2,SLC7A11,LPAR6,SLC7A7,PSAT1,MFAP5,MFAP5,FHL1,ALOX5AP,FAM129A,SERPINA1,CSTA,HMGCS1,MFAP5,PCP4,FCGBP,C13ORF15,ZNF423,DUSP22,SQLE,CYP4B1,SLC7A5,MSMO1,CNN1,ISG20,HMGCR,CTGF,DNAJB9,ARMCX1,NEBL,EIF4EBP1,HMGCS1,CRABP2,FCER1G,NUCB2,MTHFD2,THBS2,CX3CR1,HSPA13,AKR1C1,LDLR,SARS,TYROBP,CHAC1 and downregulate the expression of TYMS,FABP5,CDC25A,KIAA0101,TACC3,CA2,MLF1IP,ZWINT,SUV39H1,NUSAP1,CDC20,BST2,DTL,LIG1,HN1,IGFBP7,CCNF,FGFR3,CDC45,HOPX,ASF1B,FEN1,PCNA,BTBD3,RRM2,CCNA2,GINS1,SLBP,MCM2,RHOBTB3,BRCA1,GSTM3,GINS2,MFSD10,MCM5,PPA1,MYCBP,PIK3R1,DIRAS3,POLE2,FANCI,AURKA,STMN1,TSPAN8,MT1E,CHEK2,ENO1,CKS2,MARCKSL1,ATP1B1.	Nc1nc(NCC2CCC(CNS(=O)(=O)c3cccc4ccccc34)CC2)nc2ccccc12
Create a substance that, when applied to PC3, will enhance the gene expression for IGFBP2,EIF5A,COL11A1,COL11A1,AEBP1,CERS6,IFT57,CYP4B1,SCNN1A,SLC26A2,PRAME,CDH1,RARRES2,IFI6,THY1,HLA-DQA1,COL10A1,SFTPB,FOLR1,TMSB15A,HS2ST1,CERS6,THBS2,CLIC5,BEX4,CECR1,TUSC3,ABAT,ALDH5A1,SFTPB,EGFL6,TUSC3,CRABP2,GJA1,KIAA0226L,RNASE6,ABAT,THY1,C13ORF15,HS2ST1,ADD3,ELOVL5,HIST1H2BD,FZD6,SEMA3C,HLA-DQB1,CLGN,PFKM,HBB,MN1 and reduce it for DNAJB1,DNAJB1,CDC25A,CDC25B,FOSL1,JMJD6,SUV39H1,CEBPB,RGS2,CCNA2,PLK1,KEAP1,MAFF,RRS1,DKK1,HSPA1A,WEE1,PLK2,CDCA4,SOX9,IER5,DUSP6,AURKA,SOX9,ALDH1A1,DUSP6,NUP62,SRC,TM4SF1,MYC,WEE1,AQP3,GNAS,CCNF,CBR3,ZMIZ1,CENPA,ZFP36L2,TSC22D2,SLC6A14,IER2,DBF4,TCN1,NUP98,KIF14,SERPINB5,RPP38,DEFB1,HSPH1,FAM129A.	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C
Given a population of cells identified as PHH, create a compound that will increase the expression of the following genes: PTX3,PENK,RGS4,MMP1,SCG2,ESRP1,C14ORF132,ELANE,TARP,CDC20,COL3A1,ATP2B1,FOLR1,SST,ASCL1,PCSK1,GRIA2,BEX1,SLC2A10,ATP2B1,MPO,PRR7,C10ORF116,DOK5,PRTN3,PICALM,AZU1,FSCN1,MGP,VGLL1,NETO2,ABCC5,RGS4,FXYD6,CDH1,SNAP25,SERPINE1,COL3A1,KLK6,CYBA,CTSZ,ATP2B1,COL1A1,CDH11,MPO,MST4,TNFAIP6,QSOX1,LMNB1 and decrease the expression of the following genes: AKR1C2,AKR1C1,AKR1C1,AKR1C2,AKR1C3,FGG,AKR1B10,TGFBI,IKBKAP,ALDH1A1,CXCL14,RPS4Y1,ABLIM1,CRK,ATP1B1,GLRX,TSKU,RBP4,CFI,CP,TM4SF1,ALDH3A2,TXLNA,AQP3,TLE1,FGB,HPGD,IGL@,SQRDL,TMEM14A,PEBP1,ALDH3A2,CLEC2B,USP22,CYB5A,CYB5A,FGA,ADI1,HIST1H2AC,CYB5A,CNDP2,NR2F6,SEPP1,AGT,STOM,ECHS1,AKAP1,IL32,AKR1C1,PRSS23.	NCc1ccc(S(N)(=O)=O)cc1
For cells characterized as HOP62, generate a compound that will enhance the expression of YWHAQ, PPFIBP1, MYH9, LHFPL2, RASA2, MCL1, SFPQ, KPNA4, WDFY3, CAPN7, USP24, TM4SF1, MYO10, TNS1, GRAMD1B, PDS5A, COL7A1, DNMBP, MYL6, ZNF146, PACS1, CBLB, ACTN4, DIP2C, SMYD3, CSNK1D, NR3C1, GNB1, KIF1B, PAPPA, MAP1B, SETX, LUC7L3, MSN, PHC2, PLEC, HNRNPU and reduce the expression of HSP90B1, RPL32, HSPA5, EGR1, VIM, ASTN2, UBC, S100A10, IER3, FTL, RSRC1, TMSB10, UBE2Z, TGFBI, ZMYND8, GPI, RPS6.	COC1OC2OC3(C)CCC4C(C)CCC(C1C)C24OO3
Given a population of cells identified as HEC-1-A, create a compound that will increase the expression of the following genes: RPL31, RPS3, GIGYF2, RPS6, RPS8, RPS17, RPL11, RPS12, HNRNPH1, TXNL1, UQCRB, NCL, RPS27A, CTNNB1, RPL35, RPL37A, RPS27, RPL5, HSDL2 and decrease the expression of the following genes: CDCP1, FHIT, IGFBP3, HSPA5, SLC38A1, KRT7, PSD3, CCND1, MAP4, MBD5, TPM4, LPP, ZFP36L1, YWHAZ, TRIO, LDHA, PAX8, CTNNA1, NF1, PTPN4, NBAS, VCAN, FRAS1, PLCB4, ATP11B, HDLBP, PRRC1, RAD51B, FER, UBA6, SMARCC1, ATG7.	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)C3(O)CC
In a cell population characterized as VCAP, formulate a compound that will upregulate the expression of HMOX1,HSPA1A,HSPA6,MAP7,TXNRD1,S100A10,NEAT1,DNAJB1,DNAJB1,KRT19,ME1,HSPA6,SERPINB9,NRIP1,NRIP1,ME1,HSPH1,CD55,TPD52L1,AMACR,CLIC4 and downregulate the expression of TSPAN5,LHFP,TWIST1.	O=C(c1ccc(F)cc1)C(CN1CCCC1)c1ccccc1
Given a population of cells identified as OV7, create a compound that will increase the expression of the following genes: IL8,IL8,ATF3,NFIL3,CXCL2,ZNF586,TNFAIP3,SOX4,DDIT4,AREG,TNFAIP3,CYP1B1,CYP1B1,BHLHE40,SOX4,EGR1,COMP,XIST,XIST,BHLHE40,PTGS2,SOX4,IER3,KLF2,CXCL3,SCRG1,CCL18,CYP1B1,NFKBIA,JUN,BTG1,S100P,FHL1,JUN,CXCL5,DUSP5,FOXJ3,TSPAN13,TPM2,TSC22D3,RRAGD,JUN,BTG1,EGR2,GEM,TNFAIP6,SFRP4,TNFAIP6,SOX4,ARHGEF2 and decrease the expression of the following genes: RPS4Y1,CORO1A,HMGA2,PRKAR2B,HMG20B,RNF128,LOC100505650,SLC25A46,DDX3Y,A2M,CTSH,MAOA,TNS3,DKK1,IGFBP7,KDM5D,CXCL14,EXT1,FOLR1,ARHGDIB,DNM1L,C5ORF13,HBE1,DCT,LMO2,TNFSF10,GPR126,LGALS2,HSPA1A,NXN,PLCB1,E2F2,DNAJA1,SPRED2,IGL@,DCT,MAOA,EIF1AY,CCND1,MXRA5,CD93,ITPKB,DLK1,HSPA8,ASRGL1,FST,PCP4,APOB.	Clc1ccc2nsnc2c1NC1=NCCN1
In order to modulate gene expression in HT29, synthesize a compound that upregulates FOS,EGR1,EGR1,FOSB,ATF3,INSIG1,CYR61,JUN,PTGS2,DUSP1,SMAD3,JUN,CYR61,INSIG1,PHLDA1,SMAD3,JUN,THBS1,THBS1,ZFP36,PPP1R15A,INSIG1,PPP1R15A,NR4A1,PHLDA1,HMGCS1,NR4A2,MCL1,IL8,IER3,LDLR,MAFF,NR4A2,NR4A2,IER2,GADD45A,KLF4,CDKN1A,RGS2,CTGF,KLF6,KLF6,THBS1,HMGCS1,SERPINB2,NR4A3,GPRC5A,NPC1,EGR3,AREG and downregulates HSPA1A,HSPA8,HSPA8,PRUNE2,C3,CDKN2C,CA12,CA12,PLK1,TMEM176B,HSPA8,PPP1R3C,MREG,TSPAN12,CFB,SULF1,STEAP3,CA12,HPGD,TMEM176A,NNMT,CEBPA,HPGD,SLC37A4,TLE1,ACTG2,TBC1D16,UBE3C,SEL1L3,ASS1,TRIM14,LPL,SORL1,CAPG,AIM1,CPE,CA12,HMGN3,CCNA2,MAT2A,NDC80,ANXA4,TUBB,PSAT1,NRCAM,VAMP8,PCSK1,LOC100505650,PROM1,SAC3D1.	CC1OC(OC2CC(O)C3(CO)C4C(O)CC5(C)C(C6=CC(=O)OC6)CCC5(O)C4CCC3(O)C2)C(O)C(O)C1O
Engineer a compound for VCAP cells aimed at elevating the activity of HMOX1,HSPB1,HSPA1A,HSPA6,GADD45B,AKR1C1,BAG3,AKR1C2,ATP1B1,GPRC5A,GADD45B,KLF4,GADD45B,AKR1C1,ABHD4,MIR22HG,AKR1C2,ATP1B1,DNAJB1,NQO1,JMJD6,HSPB8,CLTB,ME1,NQO1,DNAJB1,HSPA6,CAPN2,CSRP2,CDKN1A,CLTB,JMJD6,P4HA2,BAMBI,NQO1,TXNRD1,CES1,TF,ID4,ATF3,TMEM2,ADM,HSPH1,GATA3,KLF2,HTATIP2,PPP1R15A,PPP1R15A,PHACTR2,ALDH2 and diminishing the activity of PCNA,CP,SPON1,B3GNT1,SPON1,DDX3Y,SPON1,KIAA0101,WT1,TIMM9,PTGS1,AHNAK2,STEAP1,KCNMA1,CDC20,EIF1AY,KIF20A,RPS4Y1,NMU,CFB,TYMS,SPON1,LRIG1,TOP2A,MUC16,RRM2,RAMP1,IMPDH2,MYC,BCHE,BIRC5,NUP62,NOP56,SPDEF,CA12,CEACAM5,CA12,NPDC1,CCNA2,HMMR,PAFAH1B3,CCNB2,PTTG1,TNFSF10,SCD,KDM5D,SCD,C14ORF132,PNMAL1,FAS.	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
With the goal of altering gene expression patterns in HA1E, construct a compound that increases the expression of HMOX1,HSPA1A,DDIT4,HSPA6,DNAJB1,DNAJB1,HERPUD1,PMAIP1,HSPA6,ASNS,BAG3,PMAIP1,CEBPB,TRIB3,DDIT3,ATF3,SLC7A11,GADD45A,DUSP5,SLC7A11,PPP1R15A,HSPH1,NAMPT,HSPH1,PPP1R15A,UCHL1,IL8,RGS2,TXNRD1,IFRD1,VEGFA,GCLM,CD163,CD163,CD55,STC2,DNAJB9,FTH1,HMGCS1,C13ORF15,IFRD1,SRGN,PSAT1,SQSTM1,ODC1,XBP1,CHIC2,MAFF,KLF4,HIST1H2BG and decreases the expression of HOXA5,HOXA10,SOX4,HOXA10,CCNF,HOPX,MARCKSL1,SKAP2,SLC1A1,SOX4,HPRT1,CYFIP2,SPINK2,DDB2,ANXA4,MSH6,NUAK1,SPTSSA,TNS1,SLC2A6,CKB,B3GNT1,SKAP2,C5ORF13,COL4A3,ANXA4,TP53I3,TOP2A,SOX4,CAPG,LOXL1,CD59,RHOBTB3,COASY,GRB14,SLC39A8,IGFBP7,DPYSL3,ZCCHC24,SERPINB6,NAV2,APOD,PCNA,TYMS,CDC25B,MCM2,TNNC1,CCNA2,RHOBTB3,ARL6IP5.	NS(=O)(=O)C#Cc1ccccc1
Propose a biochemical solution for HS-578T cells which aims to promote the upregulation of SDC4, MYO10, MT1X, NAMPT, PCNX2, NPM1, ANGPTL4, PKIA, TPM3, ANKRD28, STAU2, SMAD3, NRDC, WWOX, PTPRK, UGCG, SKAP2, ZMAT4, KDM3A, ITPR1, APP, TLE1, WAC, FNBP1, TENM1, JAG1, MICAL3, RNF19B, GALNT10 and the downregulation of TPM4, UGDH, ATF2, CLIC4, CDH13, P4HB, ERO1A, TIMP3, LMAN1, BTG1, TUBB6, MYOF, F3, AFF3, ACLY, HIPK2, CDC42BPA, SETBP1, SUN2, NF1, ACTR3, RBMS3, KCNMA1, VEGFC, BTBD7, TSPAN5, MAP2K4, BBX, EGFR, GPATCH2L, FBXL2.	CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO
Develop a compound targeting PC3 cells, intended to boost the transcription of CEACAM6,IL8,CEACAM6,DDIT4,IL8,S100P,HBB,CEACAM5,AREG,EREG,CSRP1,HBB,IGFBP3,HBB,IL1B,SAT1,RARRES1,IL1B,IGFBP3,RARRES1,MT1F,CXCL3,S100A8,SERPINB2,CDKN1A,CXCL1,CCL20,MAFF,SAT1,TPM2,PTGS2,MT1M,OXSR1,KCNK1,LXN,LYPD3,SLC7A5,NTS,SERPINB9,ISG20,NDRG1,MT1G,PCDH9,DUSP1,SAT1,HCAR3,VEGFA,KLF6,BCL2A1,ISG20 and suppress the transcription of AKR1C2,AKR1C2,AKR1C1,CDC45,AKR1C1,MCM3,KCTD12,KCTD12,SERPINA1,CD320,SNX7,SERPINA1,CDCA4,IL13RA2,COL3A1,DPP4,DPP4,DNMT1,FASN,HOXA10,LIPA,LGALS3BP,DPP4,MFAP4,TSEN2,TIMM8B,DAB2,MCM2,COL1A2,PCNA,NRP1,SCD,GUCY1A3,TCTA,HADH,CADM1,CD34,COL15A1,ALDH3A2,HADH.	COc1ccc(C2=Nn3c(nnc3-c3ccccc3OC)SC2)cc1OC1CCCC1
In order to modulate gene expression in HEPG2, synthesize a compound that upregulates HMOX1,CYP1B1,MSRA,GPX3,CYP1B1,CYP1B1,GPX3,ODC1,ZMAT3,SLC4A4,SORD,CCND2,FLRT3,RAB11FIP2,CTSB,IL8,UCHL1,AKAP12,RAMP1,DNAJC15,NUP93,CA12,FOLR1,C8ORF4,TFF1,VCAN,SLC16A4,IL8,ME1,RAD23B,STUB1,VCAN,AREG,SLC39A8,PIN1,SMAD3,ATF1,KCNJ16,ASAH1,HSPA1A,CHPT1,DUSP22,LAMP1,TSPAN8,CCNA1,STAT1,CPVL,ISOC1,CENPE,EXOSC4 and downregulates KIAA0528,SNX7,DLK1,FABP4,C13ORF15,XIST,KRT81,ADH1B,ADAMDEC1,ENPP2,TFAP2A,DPT,TDO2,CA2,XIST,ADH1B,CHGB,CXCL13,CSTA,ENPP2,AIM2,NRN1,RGS1,SEMA3C,CPB1,TWIST1,RNASE1,COL3A1,C10ORF10,TPBG,ALAS1,MECOM,COL3A1,COL6A1,TCF4,UBE2J1,MMP2,CAV1,FAM129A,DNMT3A,HSD17B2,CRABP1,CILP,TNNT1,TNFSF10,FZD6,TNS3,GNAS,RTN2.	NC1(c2ccccc2Cl)CCCCC1=O
Given a population of cells identified as MCF10A, create a compound that will increase the expression of the following genes: TSC22D3,TFPI,MAP7,AKR1C1,AKR1C2,CXCR4,APOD,METTL7A,IRS2,SERPINF1,CBLB,RGS2,HSPB8,CXCR4,SYNE2,HMOX1,AKR1C3,FAM129A,NUPR1,VAV3,CXCR4,AKR1C1,AKR1C2,DAPK1,PTK2,SERPINA3,GULP1,HOXC6,NR2F2,YPEL5,MAP7,SOX4,ID2,RBPMS,BTG1,TSC22D3,CCNG2,ITM2A,TLE1,IRS2,ITM2A,TFPI,HBP1,SOX4,BTG1,DNAJC12,CITED2,CFD,HERPUD1,GULP1 and decrease the expression of the following genes: FOSL1,PHLDA1,PHLDA1,DUSP6,MAT2A,MYC,G0S2,PHLDA1,DUSP6,DUSP4,EREG,HMGA2,IL1B,HBEGF,IL1B,DUSP6,HSPA1A,CCND1,CDC25A,IER3,CCND1,RRS1,PHLDA2,PODXL,PHLDA1,NUP85,GBP1,ADRB2,S100A2,ARL4C,GBP1,STEAP1,SERPINB2,SDC1,BHLHE40,NOP56,DUSP4,LEF1,ARL4C,NELL2,ADORA2B,SLC20A1,KRT14,PPBP,EPHA2,HBEGF,SDC1,CEACAM5,LDLR,FGFBP1.	NCc1ccccc1
For a given cell population identified as HA1E, design a compound to increase the expression levels of these genes: S100A8,CA2,SLC7A11,S100P,DUSP6,DUSP6,SLC7A11,DDIT3,C13ORF15,CHI3L1,HSPA6,NELL2,CHI3L1,DUSP6,HMOX1,TDO2,HES1,A2M,CYBB,TRIB3,SLC12A2,VEGFA,FGFR2,RNASE6,JAG1,DENND1B,CEBPG,KYNU,CDKN1A,HLA-DQA1,KCNJ2,CD163,WARS,SLCO3A1,APOD,IPO13,RTN1,DNAJB9,GSDMB,AIM2,AZGP1,SLC38A1,PMAIP1,SERPINA1,FGFR2,HERPUD1,CLCA2,STX3,ASNS,CYBB, while simultaneously decreasing the expression of these genes: IGFBP3,EFEMP1,IGFBP3,PRSS23,LOXL1,PDLIM2,C5ORF13,MARCKSL1,MYLK,ADD3,GPX3,EFEMP1,LAPTM4B,CXCL14,CDC42,GPX3,ADD3,ANXA6,LGALS3BP,TUBB,CD59,SERPINE1,LAPTM4B,IGL@,S100A10,SERPINE1,LAMC1,FBN1,CD59,TNC,TPM1,CFLAR,BST2,STMN1,ARL6IP5,ADD3,TMEM14A,CYTH1,COL5A1,HOXA5,IFIT1,ENO1,LAGE3,TUBB6,LUM,IGFBP4,SKP1,ARL6IP5,HPRT1,ECI2.	CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O
With the goal of altering gene expression patterns in NCI-H2347, construct a compound that increases the expression of HLA-B, RPS29, HNRNPH1, RPL35A, FTL, CLDN4, UQCRB, SUPT5H, IFITM3, RPS19, OAZ1, RPL37A, TRMT112, RPL7, NOTCH2, RPLP2, SAT1, RPL35, RPS27, GAPDH, ENO2 and decreases the expression of AP3B1, HDLBP, CSDE1, ACTB, FTH1, PRRC1, TJP1, CAPRIN1, PTPN11, PPP6R3, RNF10, ARL8B, HELZ, CANX, PLSCR1, CD2AP, LDHA, AFF4, GNAS, ZFR, AP3S1.	COc1cc2c3cc1Oc1c(OC)c(OC)cc4c1C(Cc1ccc(O)c(c1)Oc1ccc(cc1)CC3N(C)CC2)N(C)CC4
Considering a group of cells defined as A498, formulate a compound that promotes higher expression rates for HLA-B, EEF2, MYH9, RPL3, RPL37, PLEC, APLP2, CHD2, RPS17, FTL, TNIP1, RPL9, NCOR2, RPS3, RPL24, YBX1, SERPINE1, NFAT5, HNRNPA1 and lower rates for NAMPT, CXCL8, CDCP1, HSPA5, GAPDH, JAK1, RTN4, COG5, CADM1, RAI14, SEC24A, AHNAK, COPB1, HSPH1, XAF1, FNDC3A, VPS41, SDCBP, MAP4, OSMR, DDX17, AVL9, RPS6KC1, PRKDC.	O=C(O)C(=O)O.[NH-]C1CCCCC1[NH-].[Pt+2]
Given a population of cells identified as J82, create a compound that will increase the expression of the following genes: RPS12, RPL11, PSAP, KTN1, LUZP1, AKAP13, RPL30, COX6C, PCBP2, HSP90AA1, TOP2B, INTS6, HNRNPA1, TRA2A and decrease the expression of the following genes: ABI3BP, IGFBP3, FN1, COL5A1, TAS2R14, DENND1A, ARHGAP12, ZEB2, BZW1, LMAN1, DNAJC3, PFKFB4, PRKCA, TAF2, PPDPF, TAOK1, ADK, IQGAP1, ACTB, DEK, HUWE1, HSPA5, PHF20, MAP1B, RBM39, NCOA3, RPL32, VEGFA, PLCB4, ACTG1, PANK3, STAU1, UBE2D3, BACH1, MYOF, ABCA1, SPOCK1, P4HB, HNRNPC, ANKLE2, CCDC91, RHOA, PAK2, SMG6, YY1, HNRNPK, MME, MED13L, BTG1.	Cc1nc(C)c(C)nc1C
For a cell population defined as SNU-423, develop a compound that will upregulate the expression of NAMPT, RTN4, ATP2B1, UGCG, CHD2, SDC4, WDR59, CCNL1, SMC5, SETD2, UBA6, MSN, TXNIP, WDR44, OS9, ATP2B4, FER, HNRNPA1, LSM14A and downregulate the expression of HSPA5, IQCJ-SCHIP1, KCNMA1, IGFBP3, HMGA2, P4HB, CDH13, FRMPD4, CALR, ASPH, TULP4, FTH1, HSP90B1, OAS2, SMYD3, HSP90AA1, ITM2B, TPM1, CITED2, EGFR, PACSIN2, FBXL7, SLC8A1, NDRG1, LOX, LHFPL2, CUX1, LDHA, ADAM12, ARPC2, SQSTM1, TCEAL9, RBBP6, TGFBI, EPS15L1, IFI16, GANAB, ERO1B.	CCc1cc(C(N)=O)ccc1-n1nc(C(C)C)c2c(-n3cnc(-c4cnn(C)c4)c3)ccnc21
For a cell population defined as A375, develop a compound that will upregulate the expression of DDIT4,PHF15,CDKN1C,METTL7A,KRT7,SLPI,LPL,NFKBIA,LPL,CYBA,EVI2A,AUTS2,FOLR1,STOM,CCDC86,PTX3,TSC22D3,CTSC,GADD45B,TECR,ANXA3,ZBTB38,MAPT,TUBA4A,SFRP1,PIK3R1,COL4A5,CDKN1C,SPINK1,CDKN1C,PLA2G16,SFRP1,AKR1C2,PTGES,FKBP5,NAV2,TKT,STOM,NFIL3,TNFRSF10B,ZCCHC24,PPOX,PPP2R2B,PMP2,CSRP2,BST2 and downregulate the expression of HMGCS1,SULF1,SULF1,RPS4Y1,HPGD,HPGD,HPGD,AGTR1,COL6A3,TFAP2A,ESR1,MMP9,TMEM158,NPY1R,SULF1,CP,MICAL2,CPA3,IER3,TRD@,SERPINB9,TRDV3,KIAA1199,COL3A1,LEF1,DDX3Y,TUBA1A,MMP1,COL1A2,WT1,PLN,LRRC15,NRN1,CSTA,HLA-DQA1,IGFBP3,SERPINF1,ID4,TRD@,GSDMB,AEBP1,MSMB,NDUFA4L2,SERPINB3,TM4SF1,DPP4,FCER1A,COL3A1.	C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
For a cell population defined as PC3, develop a compound that will upregulate the expression of FILIP1L,TIPARP,RAB11FIP1,MYO6 and downregulate the expression of LTF,PSPH,CCND1,CD59,FABP7,NARFL.	CC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCCNC2
To influence gene expression within MCF10A, generate a chemical agent that raises the expression levels of FZD7,FZD7,PAN2,TSC22D3,METTL7A,GJA1,HMGCS1,INSIG1,GPX3,INSIG1,HMOX1,TBX2,FST,RBP4,INSIG1,DSP,TUBA1A,GPX3,TFPI,CD55,CD55,TFPI,HERPUD1,MECOM,PLS3,CBLB,EFNA1,MYO6,DHCR24,C5,SYNE2,ENPP1,HBP1,CLEC2B,CFD,PCOLCE2,PLA2G2A,PDCD4,TCTN1,ADD3,ALOX5,FN1,FABP4,CETN2,CCNG2,WNT5A,PTPN13,IGF1R,IL1R2,OSBPL1A and lowers those of CDC20,PRPF4,PARP2,EREG,SCGB2A1,JUN,ALDH1A2,PRPF4,PARP2,PARP2,SLC39A8,HES1,ACTN1,LAPTM4B,FOSL1,MAP7,CPM,IL1B,MEIS2,GLIPR1,RRS1,GRIA2,RBP1,ASRGL1,IL1B,MAMLD1,CHERP,FSCN1,ACTN1,CDC25A,RRP1B,ESR1,CHORDC1,ALDH1A3,SLC39A8,WT1,RAD51C,SCGB1D2,LAPTM4B,C11ORF9,NOV,TPD52,LPXN,SATB1,F3,MAGEB2,FTO,DUSP7,PPME1,RBKS.	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1
In order to modulate gene expression in ASC, synthesize a compound that upregulates ATP1B1,FKBP1B,FCGBP,ALDOC,DHRS2,CXADR,IFIT1,HSPA1A,F2RL1,HLA-DQA1,DNAJC12,SLC9A3R1,LAPTM5,MBP,CHN1,ISG15,ARHGEF3,PALLD,RAC2,MXI1,SKIV2L,TPD52,TPD52,FAM117A,CYFIP2,PBX3,CRABP2,SLC26A2,DACH1,CPD,SERPINA5,FABP1,NPTX2,TPD52,PAFAH1B3,PLAC8,GABARAPL2,PSPH,KAL1,NME7,NCAM1,DSP,DHRS2,DSTN,PIEZO2,PBX1,RPA3,MFAP2,RNF128,POLG2 and downregulates MAFF,ADIPOQ,ATF5,DUSP4,G0S2,DPT,TYMS,FOSL1,IGFBP6,ATF5,XBP1,PLIN1,MTHFD2,AKR1C2,GHR,CCND1,TPD52L2,RBP4,AKR1C1,COL6A2,CSDA,ADI1,SPRY2,PTGIS,CCNB2,CEBPA,GPD1,ADH1B,APOBEC3B,CSDA,AKR1C2,COL6A1,FAM57A,AKR1C1,BIRC5,DUSP4,SFRP1,RBPMS,SERPINF1,NME4,NKX3-1,ACSL1,ADH1B,HOXC6,FOXM1,DPT,KLF4,CXCL12,RCN1,STAT6.	C=C[C@@]1(C)CC(=O)[C@]2(O)[C@@]3(C)[C@@H](O)CCC(C)(C)[C@@H]3[C@H](O)[C@H](OC(C)=O)[C@@]2(C)O1
For cells characterized as HCC515, generate a compound that will enhance the expression of TSC22D3,CA12,CA12,CD9,FABP4,C13ORF15,CA12,IGKC,EZR,KRT14,SCGB1D2,PCK2,MLPH,FTH1,HIST1H2AC,KLF2,AMIGO2,KYNU,EZR,SAT1,CD24,EFHD1,PEG3,VTCN1,EZR,SAT1,CHST15,BAMBI,RHOB,CD24,SELENBP1,CD24,C14ORF132,RBM47,SAT1,MUC1,EZR,TBX2,CD24,PIP,CD24,TCTA,SPINT2,GSN,KLF6,FKBP1B,BEX1,ADCY2,ALCAM,AZGP1 and reduce the expression of PLK1,CDC45,CCL2,CDKN2A,TGFBI,CDKN2A,GINS2,FOSL1,ALDH1A3,EPN2,DTL,TMEM97,CDC25A,TM4SF1,TM4SF1,TMEM97,TM4SF1,PRDX2,VCAN,HES1,TYMS,S100A2,RGS2,CCND1,CDC6,MLF1IP,CXCL1,FABP5,COL4A2,DCK,RHOBTB3,MCAM,FGFR3,SKP2,YTHDF1,VCAN,RPL37A,HES1,IGFBP7,PCNA,MCM6,EPHB2,PRSS2,PROM1,RAMP1,MTERFD1,LACTB2,AKAP7,RPL38,MCM10.	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
With the goal of altering gene expression patterns in A375, construct a compound that increases the expression of ATF3,EGR1,DHRS2,CXCL13,EGR1,NUPR1,ADCK3,DNAJB2,GPC1,GADD45A,GADD45B,PMAIP1,XIST,XIST,DHRS2,IFRD1,BTG2,PEG10,PMAIP1,TRIM22,GADD45B,SAT1,PEG3,RBP1,TRIB3,SLC1A3,ABHD4,AKAP8L,SERPINB2,CPE,CYR61,PPP1R15A,FBLN1,DDIT3,SCGB2A2,FDXR,SAT1,RSL1D1,RND3,GADD45B,KLF10,PPP1R15A,PEG10,IFRD1,TXNL4B,CXCL9,UFM1,MAFF,DYRK3,GLUL and decreases the expression of ERBB3,EPHA3,SLC1A1,DAG1,CEACAM6,WNT5A,TGFBR2,AUTS2,PPP3CA,CSGALNACT1,CXCL14,CEACAM6,PLP1,AQP3,ETV1,EFNB2,PLEKHB1,CD24,CD24,TMEM2,TUBB2C,LXN,ABCC4,TFAP2C,HPGD,HPGD,TNC,TUBA1A,CCNA2,SOX11,HPGD,SRGN,PPP3CA,TLR4,JAG1,MAGED1,FABP7,KCNS3,FDFT1,TCN1,TUBB2C,SOX10,SOX11,PTPRZ1,DUSP4,LPAR1,GPR56,JAG1,DEGS1,SORL1.	Cc1[nH]nc2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12
Propose a biochemical solution for NCI-H2122 cells which aims to promote the upregulation of BCLAF1, SYT1, RBM25, HNRNPD, ARHGAP35, UVRAG, PHF14, PIK3CA, PCCA, RPS3, PCM1, RAD51B, DSTN, BAZ1A, PSMA7, USP7, ITGAV, UFM1 and the downregulation of BACE2, LMO7, ASPH, MYO1E, HERC4, PSAP, CDK13, SPTBN1, CD55, FBXO11, FLNB, BBX, ZNF207, VIM, AKAP13, AGAP1, PSD3, ITGB1, ADK, ACTG1.	CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(Cc1ccccc1)NC(=O)C(CC(N)=O)NC(=O)c1ccc2ccccc2n1
For cells characterized as AGS, generate a compound that will enhance the expression of ZNF131,IKZF1,AZGP1,ZNF131,S100A8,C13ORF15,MAGEA3,THY1,IL7R,PPOX,PRKCD,BLNK,TFAP2A,ZNF91,MSMB,LOC728855,TRIB2,TGFBI,MAT2A,PDZD2,IPO13,THY1,NTRK2,MSMB,METTL7A,KYNU,MKNK1,CXCL10,SULF1,AZGP1,HSP90B1,CFD,MAGEA6,F13A1,THY1,CRIP1,MT1X,SCCPDH,PTPRO,POLD4,OXCT1,HOXB2,ENPP2,VEGFA,NTRK2,VEGFA,RRP8,FAM60A,CCL20,SERPINF1 and reduce the expression of PLEKHM1,HSPB8,NGFRAP1,BEX1,MACF1,SLC26A2,TFPI2,RBPMS,GUCY1B3,PPP2R5E,DAPK1,IFI6,DLC1,CXCL14,CANT1,AGR2,WIPI1,FRZB,MGP,RBP1,WIPI1,MACF1,CITED2,NRIP1,SLC35F2,PROM1,FRZB,SVIL,FUT8,CELF2,UCHL1,TSPAN13,GSTA4,ACTB,UGDH,LGALS3BP,CDKN1B,MACF1,RPS5,SPRR2B,SOX4,ATP6V0E1,KIAA0125,DST,ASAH1,QPRT,NR1D2,IL1RL1,IL6ST,LAPTM4B.	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
With the goal of altering gene expression patterns in SHP-77, construct a compound that increases the expression of VGF, ANKH, ARHGAP26, NBAS, PAEP, RSF1, MYH9, RHOQ, FAT1, ACTN4, SLC7A2, KAT6A, NDUFA10, GRAMD4, MPRIP, KIAA0586, MCPH1, RNF40, KDM5C, KCNJ6, ANKRD17, SPOCK1, NUP160, UBAP2L, RPH3AL, STAT5B, CLASP1, IRS2, NBEA, HDAC4, MEIS2, ILF3, PJA2, HNRNPUL2, MACF1, RAD51B, SFPQ, AKAP13, XPO6, PARD3, ELAVL2, PITPNC1 and decreases the expression of RPL37, KCNB2, NELL1, PNISR, TNPO1, PDIA3, GNG4, CACNA2D1, MIF, SEZ6L2, IGFBP5, ZNF254, RNF19A, TAF1B, PAM, CGA, SMAP1, CAMSAP2, NAP1L1.	Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1
Design an experimental compound for A375 that is designed to activate the expression of PCK2,TRIB3,PROM1,ASNS,ATF3,AARS,DDIT3,STC2,PSAT1,NUPR1,APOD,PYCR1,SARS,ATF4,GABRP,SLC7A11,CARS,MARS,GARS,C6ORF48,MARS,PMAIP1,TSC22D3,IGFBP2,ASS1,DDIT4,SLC7A11,PMAIP1,SERPINA3,CEBPB,WARS,CEBPG,KRT23,TXNIP,CRABP2,XBP1,YARS,WARS,SLC3A2,NFIL3,TXNIP,FTH1,GADD45A,CARS,STC2,GDF15,PEG3,TXNIP,TXNL4B,SHMT2 and deactivate the expression of PCNA,HOPX,HSPA1A,DUSP4,TMEM2,TIPARP,AQP3,MLLT11,HSPB8,CYP1B1,SLPI,DUSP4,FOLR1,SCNN1A,PPARG,FABP5,CCND1,BMP2,CCDC165,POLE2,CXCL14,TCN1,LY6D,FAM57A,KLK11,PTGES,CYP1B1,NPY,CYP1B1,SIK1,NOP56,SMAD7,TFPI2,TMX4,FAM3C,EDNRB,AKAP8,DST,MARCKS,BMP2,GNG11,GLIPR1,HPGD,PODXL,IRS2,HHEX,LYPD3,CALM1,CCND1,HBB.	CNC(=O)c1cccc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1
For cells characterized as MCF10A, generate a compound that will enhance the expression of TSC22D3,KRT19,HIST1H2BD,IFI27,HIST1H2BK,MUC1,IGL@,MUC1,CDH1,SFTPB,LUM,THBS2,KRT17,KRT15,TRIM29,GPR56,TACSTD2,AQP3,BST2,SPINK1,COL3A1,S100A7,SFTPB,GM2A,SLPI,IGJ,H2BFS,COL3A1,KRT14,PPL,TAGLN2,DSP,STXBP1,CAPN1,NEAT1,VCAN,COL1A1,SPRR1B,HSPB8,HIST1H2AC,VCAN,CYP4B1,ITPR3,STS,IQGAP1,GM2A,TPM1,CDH3,ISG15,CD59 and reduce the expression of ATP1B1,CREB1,FOSL1,PPAP2B,CHST2,SPRY2,SOBP,HIST1H4C,CCNE2,PHACTR2,ATP1B1,PEG3,HMGA2,PHACTR2,SDC2,SPRY4,EZH2,DUSP6,PPAP2B,NID2,TMEM158,EIF5,HBEGF,SDC2,CDC25A,TRIB2,RPA3,PHLDA1,ITM2A,LYZ,EIF5,FST,G0S2,FOLH1,PHLDA1,RMI1,SLC5A6,ECI2,RNF138,IFRD2,FOLH1,COTL1,NKX3-1,SH2B3,ID4,ENPP1,CLGN,SLC20A1,TNPO1,RANBP1.	CN(c1ccccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O
To influence gene expression within MCF7, generate a chemical agent that raises the expression levels of MSMO1,ASS1,PLEKHM1,HMGCS1,CD24,CD24,CD24,LDLR,INSIG1,CD24,ACAT2,CD24,DHCR24,SCD,SLC38A1,SQLE,CCL5,CSF2RB,INHBB,CCL5,HMGCR,ALDOC,FDPS,SCD,INSIG1,SLC2A6,CXCL13,ELOVL6,SCD,FDFT1,SQLE,PPOX,VAMP1,IFNAR1,CYP51A1,HMGCR,PKP2,CAV1,SHB,NKG7,SEPT10,DLK1,INSIG1,NSDHL,FGFR2,IGJ,NEB,SC5DL,CPE,CXCL9 and lowers those of HOXC6,BCLAF1,KIF20A,SERPINA3,FOXC1,HAT1,CASP2,KIAA0101,PCDH9,DLGAP5,HPRT1,LAPTM4B,HOXC10,TNFSF13,IRX5,HLTF,LIMS1.	O=C(NCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc2ccccc2c1
Considering a group of cells defined as LNCAP, formulate a compound that promotes higher expression rates for MAMLD1,KRT19,IFI27,EPCAM,CLU,CLU,SYT1,ABCG2,C10ORF116,ABCC5,MYO6,ANXA2,VCAN,PYCARD,VCAN,ANXA2,BHLHE41,MXRA5,ANXA2,CHGB,CDH1,AZU1,RPL39L,TNFSF13,ABAT,RAB11FIP1,NPY1R,MICAL2,ABAT,BIK,RNASE2,CAPN2,LGALS3,TST,STAR,RBP1,CHP and lower rates for CCNA2,KIF20A,PLK1,TOP2A,RRM2,BIRC5,RRM2,TPX2,MELK,TOP2A,DLGAP5,UBE2C,CDKN3,KIF11,CCNA2,ASPM,ATAD2,CENPA,IGFBP5,MYBL2,TYMS,HMGB2,CDK1,MLF1IP,FOXM1,CENPF,MKI67,KIAA0101,CEP55,NDC80,PTTG1,MKI67,PBK,CDK1,MMP9,CDK1,KIF15,CDC20,HMMR,MKI67,RACGAP1,ADM,GTSE1,KIF4A,DCK,TGFBI,TACC3,KIF23,NMU,PRC1.	O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@@H]1O
Engineer a compound for HT29 cells aimed at elevating the activity of AKR1C2,AKR1C3,AKR1C1,AKR1C2,AKR1C1,AKR1B10,AKR1C1,GCLM,ABCB6,ALDH3A1,CTSL1,ADM,UGDH,CXCR7,GCLC,NRCAM,NQO1,CBR1,SLC7A11,FN1,FN1,NQO1,NQO1,FN1,CEBPA,TXN,FN1,TXNRD1,CBR3,ABHD4,PFKP,ME1,PGD,ANPEP,GCLC,GABARAPL1,LAMA3,GSTA1,GLRX,GOLM1,OLFML2A,ABCA1,MAPT and diminishing the activity of RGS2,NRIP1,OLFM4,RBM3,ZNF91,PIP,TFAP2B,IL7R,NRIP1,ZMYND8,PGLS,SOX4.	N=C(N)NC(=O)c1nc(Cl)c(N)nc1N
Develop a compound targeting MCF7 cells, intended to boost the transcription of RPS4Y1,SERPINE2,TSPAN8,MAGEA3,CYB5A,PAPSS1,TMEM45A,EIF1AY,UCHL1,TGFBI,DDX3Y,HSD17B4,MAGEA6,IGFBP7,CYB5A,IGFBP2,SGCB,P4HA1,CCL20,SORD,PLS3,CYB5A,KDM5D,IFITM1,EIF5A,SEPT10,IFITM3,LEF1,IL8,ADD3,OSBPL10,ECM1,PAN2,BNIP3L,COL1A2,PIR,S100A2,ALDOC,EMP1,CTSL2,PFKM,AMT,ADD3,STAT1,DHRS1,SYNE2,RNASE4,HAPLN1,DAPK1,IFI6 and suppress the transcription of DLD,GATA3,GATA3,GATA3,DNAJB1,XIST,NRIP1,XIST,ARID4B,CXCL14,DNAJB1,TFAP2C,CDCA4,CDKN1B,PDE4B,CDC25A,TIPARP,ZFP36L2,FZD7,IER2,TSKU,IER5,CCNF,PHF15,SMAD3,SLC30A1,TSPYL5,C1ORF106,SMAD3,KAT6B,DUSP5,CDC42EP4,RPP38,NET1,ESR1,EIF5,WTAP,MCL1,FASTKD5,ZNF217,EIF5,NRIP1,CYP1B1,GATA2,TGFBR3,NFIL3,SAMSN1,OSR2,DKK1,BAG3.	COC(=O)[C@H]1[C@H]2C[C@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC
For cells characterized as SW 1271, generate a compound that will enhance the expression of EEF1A1, NAMPT, NCL, UBR5, NAP1L1, XPO6, MYH9, CELF1, SLC2A3, RBM39, PCBP2, SNX1, CNOT8, POM121, TOP2B, WDR45B and reduce the expression of HMGA2, RAI14, KCNMA1, SERPINE2, ZBTB20, CD55, GOLGB1, SLC38A2, SLC25A37, N4BP2L2, CNOT2, PLOD2, ERC1, LDHA, PMEPA1, PODXL, TAOK1, ASAP1, VIM, RTN3, BACH1, SETX, CANX, DST, DLGAP4, THSD4, BTG1, TNRC6B, PHF3, ITGA3, INTS6, SIK2, TRPC1, STAG1, NLK, ACTG1, UGGT2, BMPR2, ELF2, ARHGEF12, TMSB10, ZNF652, KLHL29.	CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1.Cl
Given a cell population characterized by PC3, design a compound to upregulate the expression of AKR1C3,PTGS2,AGR2,DUSP4,CEACAM6,CXCL2,CEACAM6,AKR1C2,TFF1,CSNK1E,DUSP4,SERPINA1,MAL,SERPINA1,CPS1,CSGALNACT1,IL6,C10ORF116,THBD,AKR1C1,FOXG1,CPS1,SEPT6 and downregulate the expression of SERPINE1,SERPINE1,IL13RA2,CHAC1,TAX1BP3,DHCR7,ASNS,CYR61,MMP1,TAX1BP3,OAT,TLR4,MMP3,ETS1,MYOF,CAPN2.	C=CC1(C)CC(=O)C2(O)C(C)(O1)C(OC(C)=O)C(O)C1C(C)(C)CCC(O)C12C
Design an experimental compound for PC3 that is designed to activate the expression of PCK1,CITED2,MAN1A1,CITED2,SST,GSDMB,LPAR6,IGFBP5,CHGB and deactivate the expression of ALCAM,ADI1,IGFBP4,ANXA3,SORD,CCNA2,ALCAM,BIRC5,RCN1,DLGAP5,SUV39H1,IL8,ELK3,FAM57A,PRMT1,PION,NMI,KPNB1,HOXB7,PAICS,PION,PRNP,SLCO1B3,SHCBP1.	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12
Given a cell population characterized by SKB, design a compound to upregulate the expression of MX1,BST2,IFI44L,IFIT1,IFI6,IFITM1,IFI44,IFITM1,OAS2,ACAT2,IFI27,ISG15,RSAD2,LDLR,IFIT3,OAS1,SCD,OAS3,CYP51A1,IFIH1,MX2,EBP,OAS1,MSMO1,IRF7,CYP51A1,XAF1,STAT1,IFI16,EBP,IQGAP1,DHCR24,NPC1,SPINK1,DDX3Y,LDLR,HERC6,INSIG1,IRF9,IDI1,DDX58,PLSCR1,FADS1,DDX60,TMEM97,NPY1R,CBLB,CD9,MAFF,EIF1AY and downregulate the expression of IGFBP3,IGFBP3,ALDH1A1,CLU,MAP7,PLAGL1,ITM2A,CLU,LTF,TCEA2,PLK2,DLK1,CAV1,ASRGL1,CD24,MAP7,AKR1C3,MCAM,ITM2A,CD24,MCAM,TMEM47,ADH5,HSPG2,MID1,MAP7,ID1,TNFRSF21,PFN2,CFD,TCF7L2,ACTC1,IMPA2,BIRC5,MAOB,SCGB2A1,GALNT12,AKR1C1,PPAP2B,CDC42,CA1,CPA3,AKR1C2,ELANE,LOC100505650,PPP1R3C,MARCKSL1,RHOB,CD200,WWTR1.	COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC
For a given cell population identified as SNU-1, design a compound to increase the expression levels of these genes: EIF5B, ANK2, DLEU1, RPL37A, RPS25, SLC39A14, while simultaneously decreasing the expression of these genes: SLC38A2, NBEA, EGFR, CITED2, AHNAK, PDE4B, SPATS2L, NET1, RBMS3, ZEB1, FLNB, CCND1, DUSP4, BMP10, TMSB4X, PDE4D, TCF4, GAPDH, TXNRD1, GLI3, B3GALT1, VPS13B, TBL1XR1, EEF1A1, ANXA1, DUSP6, ADAM10, VCL, HDLBP, DPYD, SHC1, PKM, ITGB1, USP47, BNIP3L, PARD3, LPP, ALDOA, PYGB, PJA2, ASXL1, NFAT5, PHF3, PIAS1, TNFRSF11B, AKAP9, EVI5.	CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(NCC5CCOCC5)c([N+](=O)[O-])c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1
Design an experimental compound for HCC515 that is designed to activate the expression of INSIG1,SQLE,INSIG1,HMGCS1,IDI1,IDI1,FDFT1,CD24,MSMO1,SCD,FDFT1,INSIG1,CD24,HMGCR,LDLR,CYP51A1,HMGCR,HMGCS1,SC5DL,NSDHL,CEACAM6,SQLE,CEACAM6,CD24,FDPS,DHCR7,SQLE,DHCR24,DHCR7,LSS,SCD,EBP,CYP51A1,NSDHL,EBP,ACAT2,SCD,SCD,HMOX1,ACLY,HPGD,ACLY,HPGD,FASN,DBI,GRN,CD24,MIR22HG,C14ORF1,DBI and deactivate the expression of TUBB6,IGFBP7,CCNF,KIF14,FABP5,CCNA2,PLK1,MELK,FOLR1,LPAR1,KIF2C,RPL37A,OLFM1,IGFBP7,ENPP2,TOP2A,TOP2A,QDPR,RARRES1,NR2F2,HERC5,CYBA.	NC(=O)CCCCn1ccc(N=C(N)NCC(F)(F)F)n1
For a cell population defined as VCAP, develop a compound that will upregulate the expression of SERPINA3,LGMN,RAP1GAP,CYP1B1,AZGP1,SYNM,AREG,NUCB2,DDIT4,SLC26A2,CYP1B1,HOMER2,DUSP4,KRT14,C6ORF62,MIR22HG,CSRP1,ACOT9,CA2,ACSL3,ELOVL5,CDKN1A,IGF1R,MT1X,GLRX,TMEM30B,APOD,GPER,SORBS1,SAT1,BTG2,AZGP1,MICAL2,TPD52,SLC39A6,ABAT,NAT1,NFKBIA,SPINT2,SAT1,GLRX,POSTN,TMED10,KIAA1324,WIPI1,SAT1,STXBP1,FAM189A2,EPB41L4B,XBP1 and downregulate the expression of UBE2C,IGFBP3,CDK1,TFPI,IGFBP3,KIF20A,STMN1,ST7,VCAM1,KIF2C,PRC1,CDK1,MLF1IP,CDC25A,ERBB2,TOP2A,MYC,ESPL1,HMGB2,MELK,ESPL1,HSPD1,EPS8,CD69,MKI67,HOPX,CDK1,PTTG1,HIST1H2BK,KIF15,ASPM,CEP55,TP53,GTSE1,F12,PAFAH1B3,TTK,MCM2,HMMR,OXCT1,NPM1,LIG1,LMNB1,DLGAP5,HJURP,GINS2,KCNJ2,MKI67,TPX2,RACGAP1.	COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C
For cells characterized as MCF10A, generate a compound that will enhance the expression of TSC22D3,RARRES1,ZNF586,RARRES1,KRT7,CXCL12,SYNE2,PIK3R1,VTCN1,RARRES1,TXNIP,CYP1B1,CREB1,TFPI,KLF2,STC1,TFPI2,IGHM,TGFBR2,CYP1B1,CXCL10,DKK1,ADD3,CLU,AMIGO2,FGB,GLUL,ADD3,CLU,TRIB2,VCAN,CBLB,CYP1B1,GLUL,SERPINA1,SLC25A13,VCAN,ADD3,PHACTR2,NR2F2,TXNL4B,MYBL1,EPS8,CEBPD,NTS,CSTA,BTG1,TXNIP,GNG11,CDH1 and reduce the expression of CXCL14,MMP9,HOPX,CEACAM6,MEF2C,SPON1,RPS11,DIO2,MATN2,MYBPC1,GAL,MST4,NGFRAP1,RPL38,FGFR2,RAPGEF2,FAR2,GOLM1,MLF1,SLC26A3,CTSK,RPL27A,TCF4,LCN2,APOE,HSPA4L,IFI27,KLHL23,TYRP1,TF,CXCL2,DIO2,MMP3,CCND1,TF,MAT2A,KRT1,GJA1,SPON2,RPIA,FERMT1,RPL38,DACH1,FOSL1.	COc1cc(N2CCC(C(N)=O)CC2)ccc1Nc1nc(N)c(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1
Design an experimental compound for MCF10A that is designed to activate the expression of TSC22D3,WDTC1,AKR1C3,ID2,SESN1,TPBG,KRT19,ID1,PAPSS2,PAPSS2,VAV3,HIST1H2BK,FGFR3,AKR1C1,AKR1C1,AKR1C2,AKR1C2,CEBPA,TSPAN13,TFPI2,ANXA4,MMP7,BTG1,UCHL1,CXCL5,GPNMB,CA12,RGS2,PENK,SPINK1,LACTB2,SPINT2,CRABP2,HIST1H1C,CYBA,XIST,IGFBP5,CA12,CA12,XIST,ID2,PDCD4,PDCD4,KAT6A,DOK4,ZW10,CPM,PBX1,MAOA,AKR1B10 and deactivate the expression of ACOT9,DUSP4,DUSP6,DUSP6,FOSL1,IER3,DUSP4,DUSP6,PHLDA1,EGR1,CHN1,PHLDA1,MYC,DNAJA3,SOX9,EGR3,STX1A,MAFF,PHLDA2,HBEGF,LTF,SLC20A1,AKAP12,SOX9,CHI3L1,ETV1,EGR1,ALDH1A3,TGFBR2,F3,IER2,ANXA3,CHI3L1,ACTN1,CTGF,SPRY2,F5,CSRP1,PHLDA1,HBEGF,RRS1,HES1,EPHA2,CSGALNACT1,TNFRSF10B,RFTN1,PLAT,FHL2,F2RL1,MBP.	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1
For cells characterized as HEPG2, generate a compound that will enhance the expression of EGR1,GADD45B,GADD45B,JUN,ATF3,CXCL2,GADD45B,SLC2A6,NFKBIA,EGR1,MAFF,FOSB,CCL20,JUN,CYR61,RELB,TNFAIP3,ST6GALNAC2,TIPARP,ZFP36,HIST1H2BK,HIST1H2BD,JUNB,PSMD2,HIST1H2AC,IKBKE,GEM,CYR61,SOX9,NGFRAP1,TSC22D1,ARID4B,DUSP6,VEGFA,NR4A1,ICAM1,RND3,ADM,H2BFS,IER3,CCNL1,RFTN1,NFE2L2,HIST1H1C,IER5,TNFAIP3,IER2,SOX9,IFRD1,SOD2 and reduce the expression of B3GNT1,TMEM97,RPS11,TMED2,TMEM97,UGDH,DKK1,TMEM97,TGFBR3,RNASET2,MLEC,PSAP,FN1,PSAT1,MLEC,SFN,ZNF586,PGK1,SPON2,MMP12,OLFML3,TSPAN13,CALU,FBLN1,TBC1D16,FBLN1,TMED2,TUBB,MAT2A,DSTN,SLC16A1,HSPD1,FABP5,CALU,C20ORF30,FHL1,FBLN1,HSPA1A,CALU,FOLR1,TPD52L1,GLUD2,MARCKSL1,MGP,PTGIS,LSM4,MSH6,NME4,TMEM2,COLEC12.	COC1=C[C@]23CCCN2CCc2cc4c(cc2[C@]3(C)C1OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)O)OCO4
Considering a group of cells defined as PC3, formulate a compound that promotes higher expression rates for SCGB1D2,LGALS4,DOK5,SULT1C2,NCAM1,FXYD6,CRABP1,HAPLN1,INSR,PON3 and lower rates for LTF,RRS1,ADAMTS1,SERPINB2,FEZ2,ANXA1,UPK1B,DENND2D,SCEL,TSPAN8,RPS5,GATA2.	O=C1OC(c2ccccc2)C(c2ccccc2)N2C1C(C(=O)NCC(O)c1ccccc1)C1(C(=O)Nc3ccc(C#CC4=CCCCC4)cc31)C2c1ccccc1OCCO
Design an experimental compound for NCI-H2122 that is designed to activate the expression of RALGAPA1, SYT1, PVT1, GCC2, ZNF292, PPP2R5E, PCBP3, THOC2, ACTR2, IRS2, AGFG1, ARL15, SOCS5, LGR4, RBM39, MYO10, TCF4, PDE10A, B2M, SET, FAF1 and deactivate the expression of MYO1E, LMO7, ANXA2, BZW1, AKAP12, PAM, ACTG1, HERC4, TPM4, STAG1, LPP, ASPH, P4HB, SMCHD1, CTTN, ERO1A, ACTB, ATXN1, POLR2A, LAMB3, CBLB, SEC31A, ZNF638, ARL6IP1.	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1
To influence gene expression within NCI-H1792, generate a chemical agent that raises the expression levels of HLA-B, IFI6, HNRNPH1, GAPDH, GPI, RPL36, B2M, RPL35A, IFITM3, RPS11, LRRFIP1, HNRNPU, SIPA1L1, RPL11, IFIT3, GANAB, RPL30, RPL34, SMAD3, DHRS3, MT2A, EIF1 and lowers those of CXCL8, CDH13, OXSR1, RAB1A, MEF2A, CANX, PTGS2, HDLBP, HMGA2, ZEB2, SEC31A, MARK3, COG5, PHLDA1, RCOR1, ERO1A, RPS6KA3, JARID2, ASCC3, AKAP13, SEC24D, STC1, CCDC88A.	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O
For a cell population defined as C32, develop a compound that will upregulate the expression of NAMPT, MT2A, PTPN12, KLC1, PUM2, PI15, USP9Y, PTPRF, BCL6, EGLN1, MBD5, TTC17, LEF1, NF1, INPP5F, ACSL3, ZMYM2, ZFYVE16, TRIP12, SRRM1, CDK19 and downregulate the expression of HSPA5, CALR, HLA-B, ARPC2, IGFBP5, ATF6, CALU, INSIG1, ACLY, PDIA4, CCND1, GBE1, CTBP2, PDIA3, CANX, REV3L, AHNAK, TAX1BP1, AKT3, SEC31A, ATP2B1, JUN, MYO1E.	CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=O)C(C)C(O)C1(C)O
Design an experimental compound for A375 that is designed to activate the expression of HMOX1,ATF3,SLC7A11,MMP1,DDIT3,PCK2,NUPR1,STC2,CD55,GFPT1,ASNS,CHI3L1,CHI3L1,ASS1,STC2,XBP1,ARHGEF2,SNAI2,CHAC1,CD55,CEBPG,GADD45A,SLC7A11,SARS,CTH,WARS,VEGFA,LARP6,DNAJB9,MAFF,IFI27,ISG20,CDKN1A,PAPSS2,LY96,WARS,IL32,IFI6,GRB10,GFPT1,MICAL2,GLRX,ODC1,ISG20,TXNRD1,NPC1,GADD45B,SLC38A1,CARS,SQSTM1 and deactivate the expression of KIF20A,STMN1,CCNA2,ALDOC,H2AFX,CCNF,ASF1B,MYBL2,BIRC5,TOP2A,MCM5,LIG1,CDK1,MKI67,GTSE1,FEN1,TYMS,RRM2,CCNA2,DHCR24,KIF18B,MKI67,CDK1,NUSAP1,TOP2A,ERBB3,TUBB2C,KIF11,TUBB2C,RRM2,ASPM,KIAA0101,S100A4,B3GNT1,PLK1,SPARC,CDK1,GTSE1,MCM4,MCM3,CENPF,LMNB1,TMEM97,BIRC5,MKI67,UBE2S,NCAPD2,MKI67,CTSC,ESPL1.	OC(c1ccccc1)(c1ccccc1)C1CCNCC1
Engineer a compound for SW 1088 cells aimed at elevating the activity of ERO1A, NGLY1, ELF2, EMSY, SCD, MED13L, MLLT3, ZNF654, DGKH, MAP2K1, PJA2, PDK1, ZNF638, MXI1, UBR5, PIAS2, ENAH, ERC1, NPEPPS, SKAP2, UGCG, DIP2C, CHD2, MBD5, KDM4C, PTBP2, MTR, SMAD3, PPP3R1, PHF20, SNAP25, WDR45B, MAST2, ANKRD28, RBFOX2, KDM6A, EGLN1, TEAD1, CBLB, COL8A1, ANKRD17 and diminishing the activity of CXCL8, DCBLD2, FN1, IL6ST, STC1, PHLDA1, SERPINE2, F3, HMGA2, PRSS23, MT2A, PTPN12, LHFPL2, CLINT1, PTMA, SPOCK1, AFF3.	CC(=O)Nc1nnc(S(N)(=O)=O)s1
Engineer a compound for A498 cells aimed at elevating the activity of ZFP36L1, DDIT4, MEF2A, EFNA5, NRIP1, PDXK, RAB3GAP2, DOCK5, NAP1L1 and diminishing the activity of CADM1, AHNAK, AFF4, CLTC, PDIA4, SON, RPL34, CANX, LARP1, APOL1, SMARCA4, PDIA6, XAF1, ARFGEF2, PJA2, IGFBP3, RLIM, EGFR, BSG, KLHDC10, HIPK2, HSPA5, UPF2, VCL, SEC61B, HDLBP, RAI14, OSMR, CAV1, CCT4, TLN1, TRPC4, SMURF1, PSD3, HSPH1, EGR1, CALR.	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1
Create a substance that, when applied to PC3, will enhance the gene expression for ALDH1A1,FAM46A,NFE2,FAM117A,ADAM28,ABCG2,DLK1,IRS2,ENPP1,HIST1H2BG and reduce it for CSRP2,GOLT1B,CYCS,PARP2,EFEMP1,CAMK2N1,ANXA3,ARHGAP29,CAST,ALDH1A3,CAST,SGK1,PLAT,DLD,RECQL,TMSB15A,MMD,S100A13,SLC12A2,CD52,CYR61,SGCE,GMNN,CXADR,UPP1,ARHGDIB,PLEKHM1,PTPRK,CD44,NT5DC2,CLTB,FSTL1,DKK3.	CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CCNC(C)=O)C(C)C)C(=O)N[C@]1(C)CCCC=CCCC[C@](C)(C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O
Propose a biochemical solution for A375 cells which aims to promote the upregulation of MGP,VDAC1,GPATCH8,COMP,HDAC6,AKR1B10,MAN1A1,LYN,JAK1,COL1A1,MCAM,MMP10,SERPINF1,MAGED1,PDE4D,SPTSSA,USP11,CD9,HIST1H2BK,RBFOX2,GAS1,ATP1B1,CCDC85B,LCN2,JAG1,JAG1,PCYOX1,UBA1,AHNAK2,RBFOX2,H2BFS,YWHAZ,G6PD,CADM1,SEC23A,CHP,SPTSSA,VDAC1,PLAU,GPX3,CADM1,EPAS1,SYNE1,GSTA4,AKR1C1,PJA2,CEACAM6,GPX3,PTN,VGLL4 and the downregulation of TIMM9,MT1E,MT1F,MT1F,MT1H,MT1G,MT1X,MT1P2,PPIF,MT1X,SERPINB2,PTX3,CHI3L1,BST2,MT2A,CHI3L1,SLC39A14,CD44,LTF,CDC25A,PSMB8,ZIC1,F5,REXO2,DRAM1,BEX1,ATG3,NPM1,ACAA1,DDX21,TIMM13,RAB7L1,DPYD,GP2,CD55,TFRC,CFB,EFEMP1,POLE2,RABGGTB,GJA1,PPIF,LOX,DYNLT1,ITGAM,EVI2A,CPS1,GP2,BBOX1,MGAM.	COc1cc2c(cc1-c1c(C)noc1C)ncc1[nH]c(=O)n([C@H](C)c3ccccn3)c12
Engineer a compound for HT29 cells aimed at elevating the activity of BNIP3,TM9SF3,TFPI2,PEG3,SERPING1,SLC4A4,CLU,CHAC1,PAK1,RND3,ECI2,CRISPLD2,GULP1,GATM,PEG3,DSP,NDRG2,GRB14,BST2,CHL1,COBL,STAT1,STAT3,MT1F,SHOC2,TUBB2A,STAT3,NR2F2,MT1M,IL8,SCYL3,AHNAK2,PLAC8,FAM134C,AGTR1 and diminishing the activity of AKR1C3,S100A8,SHB,HPGD,HPGD,AKR1C1,BHLHE41,DPYSL2,AKR1C2,KYNU,HPGD,SULF1,AKR1C1,AKR1C2,CRELD2,CEACAM5,CEACAM6,KMO,ALOX5,SULF1,DNMT3A,KMO,IPO13,RAPGEF5,CEACAM6,PFKP,TPSAB1,SULF1,GUCY1A3,METTL7A,MAN1A1,CD1E,PAN2,TIMP3,KYNU,PTPRO,MB,IRAK3,CTSK,ARL4C,BAX,SHB,ARL4C,MDK,KCNN4,CD74,COLEC12,COL8A2,AHR,SH3TC1.	COC(C/C=C/C=C/CCC=CCC(C)C=CC(=CC(=O)O)CC(=O)O)C(C)=CC=C(C)C(=O)O
For a cell population defined as ASC, develop a compound that will upregulate the expression of HSPA1A,PTGS2,IL8,HMOX1,IL8,DNAJB1,CXCL2,IER3,PHLDA1,CXCL3,SQSTM1,DNAJB1,SLC7A11,DDX21,SLC7A11,HSPA6,BAG3,ASNS,CXCL5,GDF15,CXCL1,CCL20,BTG3,PHLDA1,IL7R,PLAUR,HSPH1,BTG3,MMP1,HSPH1,CD9,CHIC2,IL1B,CCL2,MICAL2,S100P,DDIT3,MYC,IER5,CD55,FUT8,NR4A2,JAG1,KIAA1199,PHLDA1,HERPUD1,MAFF,IL1B,TXNRD1,SLC3A2 and downregulate the expression of PRKAR2B,SCD,ADIPOQ,PGM1,CEBPA,SCD,SCD,CXCL12,PLIN1,RBP4,CYB5A,CYB5A,ADH1B,SCD,ALDOC,ADH1B,CYB5A,SLC4A4,GHR,DHCR24,CES1,CFD,FABP4,ACACB,PTGIS,TMEM47,FASN,CLIC3,SCARB1,LUM,INSIG1,GYG2,MGP,ACACB,GYG2,PPP2R5A,NDN,METTL7A,ACLY,SCUBE2,EBP,ENPP2,DBI,DBI,PALMD,TNS1,GAS1,CKB,GPX3,EBP.	COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c1ccc(O)cc1
Develop a compound targeting HS-578T cells, intended to boost the transcription of FTH1, RPLP2, RPS12, MT2A, EEF2, PLEC, RPS3, GAPDH, FKBP10, RPL37A, RPL36, RPS16, TNIP1, RPS29, CALR, ISG15, COX6C, IFI6, MYH9, TMEM158, RPL31, ENO1, IFITM3, TMSB10 and suppress the transcription of IL6ST, GSK3B, SLC5A3, PABPC1, RBPJ, ADNP, INHBA, UBR5, ANXA5, SPAG9, COPB2, GNB1, SQLE, CADM1, TFG, AFF3, BACH1, MLLT10, LMAN1, YEATS2, AFF4, SRP54, CAMK1D, CBLB, CNOT2, CUL1, TENM3, TAOK1, EGFR, PRR16, CXCL8, ACLY, TSPAN5, ZFPM2, PAK2.	CN1CCc2nc(C(=O)NC3CC(C(=O)N(C)C)CCC3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1.Cc1ccc(S(=O)(=O)O)cc1.O
For a cell population defined as HepG2/C3A, develop a compound that will upregulate the expression of EEF1A1, BCL2L1, APLP2, TGFBR2, PDCD6IP, CPSF6, YAP1, ASAP2, NCL, SMURF1, NFE2L1, RPL3, PMM2, LDHA, LRRFIP2 and downregulate the expression of EGR1, RPL7, TPM4, TMEM123, RPLP0, PTK2, CAMK2N1, PLIN2, SERBP1, RDX, PDIA6, RPL24, CTSB, VDAC1, RPL35A, APOA2, HINT1, GNB1, IQSEC1, RAB7A, RPLP1, DNAJC12, PCBP1, GAPDH, DLC1, YBX1, CSGALNACT1, PDE4D, RPS6, MET, ARIH1.	COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(OCCO)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C
